Mycobacterium vaccae Schering 260 is an obligate aerobe, mesophilic, rod-shaped human pathogen that was isolated from cow's milk.
rod-shaped obligate aerobe mesophilic human pathogen genome sequence 16S sequence| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Actinomycetota |
| Class Actinomycetes |
| Order Mycobacteriales |
| Family Mycobacteriaceae |
| Genus Mycobacterium |
| Species Mycobacterium vaccae |
| Full scientific name Mycobacterium vaccae Bönicke and Juhasz 1964 (Approved Lists 1980) |
| Synonyms (1) |
| @ref: | 10934 |
| multimedia content: | DSM_43292.jpg |
| multimedia.multimedia content: | https://www.dsmz.de/microorganisms/photos/DSM_43292.jpg |
| caption: | Medium 645 37°C |
| intellectual property rights: | © Leibniz-Institut DSMZ |
| manual_annotation: | 1 |
| @ref: | 10934 |
| multimedia content: | DSM_43292-1.jpg |
| multimedia.multimedia content: | https://www.dsmz.de/microorganisms/photos/DSM_43292-1.jpg |
| intellectual property rights: | © Leibniz-Institut DSMZ |
| manual_annotation: | 1 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 10934 | MIDDLEBROOK MEDIUM (DSMZ Medium 645) | Medium recipe at MediaDive | Name: MIDDLEBROOK MEDIUM (DSMZ Medium 645) Composition: Bacto Middlebrook 7H10 agar 20.9945 g/l Glycerol Distilled water | ||
| 36254 | MEDIUM 55 - for Mycobacterium | ||||
| 10934 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water | ||
| 123767 | CIP Medium 55 | Medium recipe at CIP |
| 67770 | Observationquinones: MK-9(H2) |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 68382 | alkaline phosphatase | - | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 123767 | amylase | - | ||
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 123767 | beta-galactosidase | - | 3.2.1.23 | |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 123767 | caseinase | - | 3.4.21.50 | |
| 123767 | catalase | + | 1.11.1.6 | |
| 68382 | cystine arylamidase | + | 3.4.11.3 | from API zym |
| 123767 | DNase | - | ||
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 123767 | gamma-glutamyltransferase | - | 2.3.2.2 | |
| 123767 | gelatinase | - | ||
| 123767 | lecithinase | - | ||
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 123767 | lipase | - | ||
| 68382 | lipase (C 14) | - | from API zym | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 123767 | oxidase | - | ||
| 123767 | protease | - | ||
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 123767 | tween esterase | + | ||
| 123767 | urease | + | 3.5.1.5 | |
| 68382 | valine arylamidase | - | from API zym |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 67770 | ASM165524v1 assembly for Mycolicibacterium vaccae 95051 | complete | 1354275 | 99.32 | ||||
| 67770 | ASM155271v1 assembly for Mycolicibacterium vaccae NBRC 14118 = CIP 105934 | contig | 1223499 | 3.89 | ||||
| 66792 | ASM2582120v1 assembly for Mycolicibacterium vaccae DSM 43292 | contig | 1810 |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 67770 | Mycobacterium vaccae 16S ribosomal RNA gene, partial sequence | AF480591 | 1439 | 1810 | ||
| 67770 | M.vaccae 16S ribosomal RNA, part | X55601 | 1447 | 1810 | ||
| 124043 | Mycolicibacterium vaccae strain CECT 3019 16S ribosomal RNA gene, partial sequence. | OK538993 | 823 | 1810 | ||
| 124043 | Mycobacterium vaccae strain CIP 105934 16S ribosomal RNA gene, partial sequence. | AF547980 | 542 | 1810 |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125439 | oxygen_tolerance | BacteriaNetⓘ | obligate aerobe | 99.10 | no |
| 125439 | gram_stain | BacteriaNetⓘ | positive | 96.00 | no |
| 125439 | motility | BacteriaNetⓘ | no | 71.50 | no |
| 125439 | spore_formation | BacteriaNetⓘ | no | 61.70 | no |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125438 | gram-positive | gram-positiveⓘ | yes | 90.24 | no |
| 125438 | anaerobic | anaerobicⓘ | no | 97.82 | yes |
| 125438 | spore-forming | spore-formingⓘ | no | 60.97 | no |
| 125438 | aerobic | aerobicⓘ | yes | 87.60 | yes |
| 125438 | thermophilic | thermophileⓘ | no | 96.00 | yes |
| 125438 | flagellated | motile2+ⓘ | no | 88.00 | no |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Pathogenicity | Rapidly Growing Mycobacterium Species: The Long and Winding Road from Tuberculosis Vaccines to Potent Stress-Resilience Agents. | Amoroso M, Langgartner D, Lowry CA, Reber SO. | Int J Mol Sci | 10.3390/ijms222312938 | 2021 | |
| Phylogeny | Catheter-associated bacteremia by Mycobacterium senegalense in Korea. | Oh WS, Ko KS, Song JH, Lee MY, Ryu SY, Taek S, Kwon KT, Lee JH, Peck KR, Lee NY. | BMC Infect Dis | 10.1186/1471-2334-5-107 | 2005 | |
| A novel real-time PCR assay for specific detection and quantification of Mycobacterium avium subsp. paratuberculosis in milk with the inherent possibility of differentiation between viable and dead cells. | Dzieciol M, Volgger P, Khol J, Baumgartner W, Wagner M, Hein I. | BMC Res Notes | 10.1186/1756-0500-3-251 | 2010 | ||
| Phylogeny | Phylogenomics and Comparative Genomic Studies Robustly Support Division of the Genus Mycobacterium into an Emended Genus Mycobacterium and Four Novel Genera. | Gupta RS, Lo B, Son J. | Front Microbiol | 10.3389/fmicb.2018.00067 | 2018 | |
| Phenotype | Mycobacterium vaccae ATCC 15483T administered to nulliparous C57BL/6N mice prior to mating protects their male offspring against the negative consequences of prenatal stress. | Schiele J, Tsai PL, Ernst G, Blank C, Beck S, Schimmele T, Burth E, Gebauer D, Lowry CA, Noschka R, Langgartner D, Stenger S, Haffner-Luntzer M, Slattery DA, Reber SO. | Brain Behav Immun | 10.1016/j.bbi.2025.106169 | 2025 | |
| Pathogenicity | Protective effects of Mycobacterium vaccae ATCC 15483 against "Western"-style diet-induced weight gain and visceral adiposity in adolescent male mice. | Desmond LW, Dawud LM, Kessler LR, Akonom T, Hunter EAH, Holbrook EM, Andersen ND, Sterrett JD, Boateng DA, Stuart BJ, Guerrero L, Gebert MJ, Tsai PS, Langgartner D, Reber SO, Frank MG, Lowry CA. | Brain Behav Immun | 10.1016/j.bbi.2024.12.029 | 2025 | |
| Pathogenicity | Effects of repeated intragastric administrations with heat-inactivated Mycobacterium aurum DSM 33539 on the stress-induced aggravation of dextran sulfate sodium (DSS) colitis in C57BL/6N mice. | Langgartner D, Weiss AJ, Amoroso M, Sterrett JD, Lowry CA, Reber SO. | Front Neurosci | 10.3389/fnins.2024.1488603 | 2024 | |
| Evolutionary Aspects of Diverse Microbial Exposures and Mental Health: Focus on "Old Friends" and Stress Resilience. | Dawud LM, Holbrook EM, Lowry CA. | Curr Top Behav Neurosci | 10.1007/7854_2022_385 | 2023 | ||
| VLX600, an anticancer iron chelator, exerts antimicrobial effects on Mycobacterium abscessus infections. | Oh J, Choi S, Seo H, Kim DH, Kim H, Lee D, Jang J, Jung S, Lee J-Y, Kim Z, Yim J-J, Kwak N, Kim B-J. | Microbiol Spectr | 10.1128/spectrum.00719-25 | 2025 | ||
| Mycobacterium vaccae Adaptation to Disinfectants and Hand Sanitisers, and Evaluation of Cross-Tolerance with Antimicrobials. | de Carvalho CCCR, Teixeira R, Fernandes P. | Antibiotics (Basel) | 10.3390/antibiotics9090544 | 2020 | ||
| In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria. | Zhang T, Du J, Dong L, Wang F, Zhao L, Jia J, Wang C, Cheng M, Yu X, Huang H. | Microbiol Spectr | 10.1128/spectrum.03238-22 | 2023 | ||
| Mycobacterial Response to Organic Solvents and Possible Implications on Cross-Resistance With Antimicrobial Agents. | Pacifico C, Fernandes P, de Carvalho CCCR. | Front Microbiol | 10.3389/fmicb.2018.00961 | 2018 | ||
| Adaptation of Bacteria to Antineoplastic Agents Involves Persister Cells and Increases Resistance to Antibiotics. | de Carvalho CCCR. | Bioengineering (Basel) | 10.3390/bioengineering9080355 | 2022 | ||
| In vitro and intracellular inhibitory activities of nosiheptide against Mycobacterium abscessus. | Zhu R, Yu X, Zhang T, Kong Y, Wang F, Jia J, Xue Y, Huang H. | Front Microbiol | 10.3389/fmicb.2022.926361 | 2022 | ||
| Pathogenicity | In Vitro Activities of Bedaquiline and Delamanid against Nontuberculous Mycobacteria Isolated in Beijing, China. | Yu X, Gao X, Li C, Luo J, Wen S, Zhang T, Ma Y, Dong L, Wang F, Huang H. | Antimicrob Agents Chemother | 10.1128/aac.00031-19 | 2019 | |
| Gran1: A Granulysin-Derived Peptide with Potent Activity against Intracellular Mycobacterium tuberculosis. | Noschka R, Wondany F, Kizilsavas G, Weil T, Weidinger G, Walther P, Michaelis J, Stenger S. | Int J Mol Sci | 10.3390/ijms22168392 | 2021 | ||
| The Many Hosts of Mycobacteria 9 (MHM9): A conference report. | Klever AM, Alexander KA, Almeida D, Anderson MZ, Ball RL, Beamer G, Boggiatto P, Buikstra JE, Chandler B, Claeys TA, Concha AE, Converse PJ, Derbyshire KM, Dobos KM, Dupnik KM, Endsley JJ, Endsley MA, Fennelly K, Franco-Paredes C, Hagge DA, Hall-Stoodley L, Hayes D, Hirschfeld K, Hofman CA, Honda JR, Hull NM, Kramnik I, Lacourciere K, Lahiri R, Lamont EA, Larsen MH, Lemaire T, Lesellier S, Lee NR, Lowry CA, Mahfooz NS, McMichael TM, Merling MR, Miller MA, Nagajyothi JF, Nelson E, Nuermberger EL, Pena MT, Perea C, Podell BK, Pyle CJ, Quinn FD, Rajaram MVS, Mejia OR, Rothoff M, Sago SA, Salvador LCM, Simonson AW, Spencer JS, Sreevatsan S, Subbian S, Sunstrum J, Tobin DM, Vijayan KKV, Wright CTO, Robinson RT. | Tuberculosis (Edinb) | 10.1016/j.tube.2023.102377 | 2023 | ||
| Pathogenicity | Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7. | Pulido D, Torrent M, Andreu D, Nogues MV, Boix E. | Antimicrob Agents Chemother | 10.1128/aac.00428-13 | 2013 | |
| Metabolism | Growth of mycobacteria on carbon monoxide and methanol. | Park SW, Hwang EH, Park H, Kim JA, Heo J, Lee KH, Song T, Kim E, Ro YT, Kim SW, Kim YM. | J Bacteriol | 10.1128/jb.185.1.142-147.2003 | 2003 | |
| Pathogenicity | Lansoprazole is an antituberculous prodrug targeting cytochrome bc1. | Rybniker J, Vocat A, Sala C, Busso P, Pojer F, Benjak A, Cole ST. | Nat Commun | 10.1038/ncomms8659 | 2015 | |
| Enzymology | Development of a novel PCR restriction analysis of the hsp65 gene as a rapid method to screen for the Mycobacterium tuberculosis complex and nontuberculous mycobacteria in high-burden countries. | Varma-Basil M, Garima K, Pathak R, Dwivedi SK, Narang A, Bhatnagar A, Bose M. | J Clin Microbiol | 10.1128/jcm.03067-12 | 2013 | |
| Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis. | Skinner MA, Yuan S, Prestidge R, Chuk D, Watson JD, Tan PL. | Infect Immun | 10.1128/iai.65.11.4525-4530.1997 | 1997 | ||
| Exposure to mycobacteria primes the immune system for evolutionarily diverse heat shock proteins. | Qazi KR, Qazi MR, Julian E, Singh M, Abedi-Valugerdi M, Fernandez C. | Infect Immun | 10.1128/iai.73.11.7687-7696.2005 | 2005 | ||
| Littoral lichens as a novel source of potentially bioactive Actinobacteria. | Parrot D, Antony-Babu S, Intertaglia L, Grube M, Tomasi S, Suzuki MT. | Sci Rep | 10.1038/srep15839 | 2015 | ||
| Enzymology | Development and evaluation of a novel multicopy-element-targeting triplex PCR for detection of Mycobacterium avium subsp. paratuberculosis in feces. | Sevilla IA, Garrido JM, Molina E, Geijo MV, Elguezabal N, Vazquez P, Juste RA. | Appl Environ Microbiol | 10.1128/aem.01026-14 | 2014 | |
| Enzymology | Reverse transcription-PCR detection of Mycobacterium leprae in clinical specimens. | Kurabachew M, Wondimu A, Ryon JJ. | J Clin Microbiol | 10.1128/jcm.36.5.1352-1356.1998 | 1998 | |
| Enzymology | Detection and identification of mycobacteria in formalin-fixed, paraffin-embedded tissues by nested PCR and restriction enzyme analysis. | Bascunana CR, Belak K. | J Clin Microbiol | 10.1128/jcm.34.10.2351-2355.1996 | 1996 | |
| Enzymology | Comparative evaluation of the new version of the INNO-LiPA Mycobacteria and genotype Mycobacterium assays for identification of Mycobacterium species from MB/BacT liquid cultures artificially inoculated with Mycobacterial strains. | Padilla E, Gonzalez V, Manterola JM, Perez A, Quesada MD, Gordillo S, Vilaplana C, Pallares MA, Molinos S, Sanchez MD, Ausina V. | J Clin Microbiol | 10.1128/jcm.42.7.3083-3088.2004 | 2004 | |
| Rapid detection of Mycobacterium avium in stool samples from AIDS patients by immunomagnetic PCR. | Li Z, Bai GH, von Reyn CF, Marino P, Brennan MJ, Gine N, Morris SL. | J Clin Microbiol | 10.1128/jcm.34.8.1903-1907.1996 | 1996 | ||
| Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. | Brandt L, Feino Cunha J, Weinreich Olsen A, Chilima B, Hirsch P, Appelberg R, Andersen P. | Infect Immun | 10.1128/iai.70.2.672-678.2002 | 2002 | ||
| Genotypic variation and stability of four variable-number tandem repeats and their suitability for discriminating strains of Mycobacterium leprae. | Truman R, Fontes AB, De Miranda AB, Suffys P, Gillis T. | J Clin Microbiol | 10.1128/jcm.42.6.2558-2565.2004 | 2004 | ||
| DNA isolated from Mycobacterium leprae: genome size, base ratio, and homology with other related bacteria as determined by optical DNA-DNA reassociation. | Imaeda T, Kirchheimer WF, Barksdale L. | J Bacteriol | 10.1128/jb.150.1.414-417.1982 | 1982 | ||
| Serological response of patients with leprosy to a 28- to 30-kilodalton protein doublet from early cultures of Mycobacterium bovis BCG. | Pessolani MC, Rumjanek FD, Marques MA, de Melo FS, Sarno EN. | J Clin Microbiol | 10.1128/jcm.27.10.2184-2189.1989 | 1989 | ||
| Enzymology | Group-specific small-subunit rRNA hybridization probes to characterize filamentous foaming in activated sludge systems. | de los Reyes FL, Ritter W, Raskin L. | Appl Environ Microbiol | 10.1128/aem.63.3.1107-1117.1997 | 1997 | |
| Compilation of small ribosomal subunit RNA structures. | Neefs JM, Van de Peer Y, De Rijk P, Chapelle S, De Wachter R. | Nucleic Acids Res | 10.1093/nar/21.13.3025 | 1993 | ||
| Genomics Insights into Mycolicibacterium Hassiacum Causing Infection in a Cat with Pyogranulomatous Dermatitis and Panniculitis. | Smedile D, Iurescia M, Carfora V, Cocumelli C, Palmerini T, Diaconu EL, Congiu I, Donati V, Stravino F, Sorbara L, Romano E, Caprioli A, Battisti A. | Pathogens | 10.3390/pathogens13090785 | 2024 | ||
| The Sex-Specific Effects of Early Life Adversity and Chronic Psychosocial Stress during Adulthood on Bone Are Mitigated by Mycobacterium vaccae NCTC 11659 in Mice. | Gebauer D, Schimmele T, Mazzari G, Kruger BT, Zemui M, Ignatius A, Langgartner D, Haffner-Luntzer M, Reber SO. | Neuroimmunomodulation | 10.1159/000543507 | 2025 | ||
| Comparative Analysis of Virulence Genes in Non-Tuberculosis Mycobacteria (NTM) Isolated from Kenyan Camel Milk Suggests Potential Pathogenicity. | Wanjiru ML, Matofari JW, Bebe BO, Njeru MJ, Nduko JM. | Curr Microbiol | 10.1007/s00284-025-04244-8 | 2025 | ||
| Pathogenicity | Mycobacterium vaccae attenuates airway inflammation by inhibiting autophagy and activating PI3K/Akt signaling pathway in OVA-induced allergic airway inflammation mouse model. | Xiao H, Tang AZ, Xu ML, Chen HL, Wang F, Li CQ. | Mol Immunol | 10.1016/j.molimm.2024.07.006 | 2024 | |
| Mycobacterium vaccae alleviates allergic airway inflammation and airway hyper-responsiveness in asthmatic mice by altering intestinal microbiota. | Xiao H, Fang LT, Tang AZ, Chen HL, Xu ML, Wei XS, Pang GD, Li CQ. | Immunology | 10.1111/imm.13750 | 2024 | ||
| Bovine Tuberculosis in Wild Boar (Sus scrofa) in Slovenia. | Pate M, Zajc U, Pirs T, Ocepek M, Krt B. | J Wildl Dis | 10.7589/jwd-d-23-00123 | 2024 | ||
| Pathogenicity | Mycobacterium vaccae protects against glucocorticoid resistance resulting from combined physical and psychosocial trauma in mice. | Langgartner D, Amoroso M, Kempter E, Kustermann M, Scheurer J, Lowry CA, Strauss G, Reber SO. | Brain Behav Immun | 10.1016/j.bbi.2023.01.018 | 2023 | |
| Performance comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in detecting Mycobacterium tuberculosis infection among HIV patients in China. | Lu P, Yang H, Ge F, Wu K, Lian Y, Ding X, Pan J, Ding H, Lu W, Liu Q, Zhu L. | PeerJ | 10.7717/peerj.19195 | 2025 | ||
| Inactivated Mycobacterial Vaccine Nebulized Inhalation: A Effective Therapy for the Prevention and Treatment of Respiratory Diseases? | Jiang X, Sun Q, Huang Y, Deng Y, Li C. | Clin Respir J | 10.1111/crj.70101 | 2025 | ||
| Pathogenicity | Aerosol inhalation of Mycobacterium vaccae ameliorates airway structural remodeling in chronic asthma mouse model. | Zhang QN, Xiao H, Fang LT, Sun QX, Li LD, Xu SY, Li CQ. | Exp Lung Res | 10.1080/01902148.2022.2115166 | 2022 | |
| Genetics | Microbial exchange at the wildlife-livestock interface: insights into microbial composition, antimicrobial resistance and virulence factor gene dynamics in grassland ecosystems. | Kauer L, Sapountzis P, Imholt C, Berens C, Kuehn R. | Anim Microbiome | 10.1186/s42523-025-00448-2 | 2025 | |
| Mycobacterium tuberculosis infection status and associated factors among household close contacts of rifampicin-resistant pulmonary tuberculosis patients: A single-center cross-sectional study. | Shi Z, Peng J, Li X, Fu X, Zou L, Chen Q, Huang T, Zhou Y, Zhu H, Wang Y, Tang S, Wu G. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2025.100561 | 2025 | ||
| Dendritic Cell Vaccine Harboring Inactivated Mycobacteria Induces Immune Protection Against Tuberculosis in Murine Models and is Well Tolerated in Humans. | Hu Z, Liu X, Wang J, Gu L, Chen Z, Xia L, Yang H, Xu J, Huang X, Wang H, Lu S, Fan XY. | Small Sci | 10.1002/smsc.202400355 | 2025 | ||
| Dust to Disease: Cavitary Lung Lesion With Mycobacterium kansasii in a Black Lung Patient. | Machineni NVK, Gullapalli D, Tangutoori S, Tipparthi A, Lahori S, Khater F, Ganti SS. | J Investig Med High Impact Case Rep | 10.1177/23247096251348906 | 2025 | ||
| Development of a Multienzyme Cascade for Salvianolic Acid A Synthesis from l-Tyrosine. | Zhang M, Zhong J, Zhang Y, Wang W, Zhao W, Hu S, Lv C, Huang J, Mei L. | ACS Omega | 10.1021/acsomega.4c09986 | 2025 | ||
| Predictors of Tuberculosis Preventive Treatment Completion in College Students: A High Adherence Study in China. | Liu C, Jing R, Li S, Zhang W, Dong Y, Dong H, Xue R, Jin J, Ju Y. | Infect Drug Resist | 10.2147/idr.s523021 | 2025 | ||
| Genetics | Antibacterial Siderophores of Pandoraea Pathogens and Their Impact on the Diseased Lung Microbiota. | Herzog E, Ishida K, Scherlach K, Chen X, Bartels B, Niehs SP, Cheaib B, Panagiotou G, Hertweck C. | Angew Chem Int Ed Engl | 10.1002/anie.202505714 | 2025 | |
| Pathogenicity | Effects of Mycobacterium vaccae Aerosol Inhalation on Airway Inflammation in Asthma Mouse Model. | Xiao H, Zhang QN, Sun QX, Li LD, Xu SY, Li CQ. | J Aerosol Med Pulm Drug Deliv | 10.1089/jamp.2021.0008 | 2021 | |
| Investigations into the biosynthesis of stieleriacines and related N-acyl tyrosines by comparative genomics, knock-out studies and total synthesis of epi-stieleriacine C. | Sauer M, Staack M, Balluff S, Jogler C, Kallscheuer N, Beemelmanns C. | Commun Chem | 10.1038/s42004-025-01654-4 | 2025 | ||
| Pathogenicity | A review of the efficacy of clinical tuberculosis vaccine candidates in mouse models. | Del Pozo-Ramos L, Kupz A. | Front Immunol | 10.3389/fimmu.2025.1609136 | 2025 | |
| Mycobacterium vaccae Nebulization in the Treatment of COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial. | Lin YR, Wu FY, Xiao H, Huang JL, Gong BB, Li YL, Lu N, Jiang XH, Sun QX, Zhang JF, Hu JT, Zhao YX, Li CQ. | J Aerosol Med Pulm Drug Deliv | 10.1089/jamp.2020.1628 | 2021 | ||
| Mycobacterium vaccae Lysate Induces Anti-Allergic Immune Response In Vitro. | Strygin AV, Nesmiyanov PP, Petrov VI, Tolkachev BE, Morkovin EI, Gutov MV, Strygina AO. | Bull Exp Biol Med | 10.1007/s10517-020-05039-6 | 2020 | ||
| Discovery and Biosynthesis of Celluxanthenes, Antibacterial Arylpolyene Alkaloids From Diverse Cellulose-Degrading Anaerobic Bacteria. | Ishida K, Krabbe J, Meisinger PR, Shabuer G, Schieferdecker S, Cyrulies M, Tank C, Barnes E, Paetz C, Hertweck C. | Angew Chem Int Ed Engl | 10.1002/anie.202503697 | 2025 | ||
| Pathogenicity | Notch Signaling Pathway Interfering as a Possible Asthma Treatment: A Narrative Review. | Wang J, Yan K, Ma L, Yan X, Meng Z, Li JA, Wang M, Du C, Yu Y. | J Asthma Allergy | 10.2147/jaa.s504925 | 2025 | |
| Treatment outcomes in cavitary multidrug-resistant/rifampicin-resistant tuberculosis and risk factors for cavity closure: a retrospective cohort study in Southwest China. | Chen Q, Zou L, Tang X, Huang T, Guo Z, Sun J, Lu X, Tang S, Wu G, He W. | Sci Rep | 10.1038/s41598-025-06080-z | 2025 | ||
| Pathogenicity | Subcutaneous Mycobacterium vaccae ameliorates the effects of early life adversity alone or in combination with chronic stress during adulthood in male and female mice. | Mazzari G, Lowry CA, Langgartner D, Reber SO. | Neurobiol Stress | 10.1016/j.ynstr.2023.100568 | 2023 | |
| Enzymology | From six to zero per cent Mycobacterium avium subsp. paratuberculosis milk ELISA positivity in three years - probably induced by Mycobacterium vaccae. | Elad D, Lysnyansky I, Falk R, Blum SE, Weisbelith L, Mikula I, Shwimmer A. | J Dairy Res | 10.1017/s0022029920000278 | 2020 | |
| Pathogenicity | Streptomyces rimosus-rich soil exposure alleviates depression-like behaviors by modulating neuroinflammation and synaptic plasticity in mice with stress. | Kim JH, Kim JS, Eo H, Yang S, Lee CH, Park SA, Oh MS. | Sci Rep | 10.1038/s41598-025-13885-5 | 2025 | |
| Efficacy of leprosy vaccines across the globe: A systematic review & meta-analysis of randomized controlled trials. | Dasgupta S, Mukherjee S, Bagchi C, Das S, Saha I, Kalita M, Bagepally BS, Guha SK. | Indian J Med Res | 10.25259/ijmr_1289_2024 | 2024 | ||
| MYCOBACTERIA IN SKIN LESIONS AND THE HABITAT OF THE ENDANGERED HOUSTON TOAD (ANAXYRUS HOUSTONENSIS). | Vemulapally S, Villamizar A, Guerra T, Tocidlowski ME, Spradley M, Mays S, Forstner MRJ, Hahn D. | J Wildl Dis | 10.7589/jwd-d-20-00145 | 2021 | ||
| One-Week Nebulization of Mycobacterium vaccae Can Protect Against Pulmonary Respiratory Syncytial Virus Infection in Balb/c Mice. | Jiang XH, Li CQ, Feng GY, Luo MJ, Sun QX. | J Aerosol Med Pulm Drug Deliv | 10.1089/jamp.2019.1573 | 2020 | ||
| Pathogenicity | Mycobacterium vaccae nebulization protects Balb/c mice against bronchial asthma through neural mechanisms. | Jiang XH, Li CQ, Feng GY, Luo MJ, Sun QX, Huang J. | J Asthma | 10.1080/02770903.2020.1761381 | 2021 | |
| Effects of immunization with heat-killed Mycobacterium vaccae on autism spectrum disorder-like behavior and epileptogenesis in a rat model of comorbid autism and epilepsy. | Smith ZZ, Kubiak RA, Arnold MR, Loupy KM, Taylor JA, Crist TG, Bernier AE, D'Angelo HM, Heinze JD, Lowry CA, Barth DS. | Brain Behav Immun | 10.1016/j.bbi.2020.05.034 | 2020 | ||
| Subcutaneous Mycobacterium vaccae promotes resilience in a mouse model of chronic psychosocial stress when administered prior to or during psychosocial stress. | Amoroso M, Bottcher A, Lowry CA, Langgartner D, Reber SO. | Brain Behav Immun | 10.1016/j.bbi.2019.12.018 | 2020 | ||
| A multicomponent propane monooxygenase catalyzes the initial degradation of methyl tert-butyl ether in Mycobacterium vaccae JOB5. | Chen Y, Ren H, Kong X, Wu H, Lu Z. | Appl Environ Microbiol | 10.1128/aem.01187-23 | 2023 | ||
| Metabolism | Alzheimer's Disease: Protective Effects of Mycobacterium vaccae, a Soil-Derived Mycobacterium with Anti-Inflammatory and Anti-Tubercular Properties, on the Proteomic Profiles of Plasma and Cerebrospinal Fluid in Rats. | Loupy KM, Lee T, Zambrano CA, Elsayed AI, D'Angelo HM, Fonken LK, Frank MG, Maier SF, Lowry CA. | J Alzheimers Dis | 10.3233/jad-200568 | 2020 | |
| Pathogenicity | Intranasal Mycobacterium vaccae administration prevents stress-induced aggravation of dextran sulfate sodium (DSS) colitis. | Amoroso M, Kempter E, Eleslambouly T, Lowry CA, Langgartner D, Reber SO. | Brain Behav Immun | 10.1016/j.bbi.2019.05.005 | 2019 | |
| The first case of Mycobacterium vaccae sepsis in a non-Hodgkin lymphoma patient: biological understandings and clinical consequencies. | Congedo P, Gardellini A, Corich L, Papa A, Turrini M. | Access Microbiol | 10.1099/acmi.0.000161 | 2020 | ||
| Pathogenicity | Progress of single-cell sequencing technology in immunotherapy for tuberculosis. | Fan X, Chen M, Wu D, Lin Y, Chen X. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1666630 | 2025 | |
| Effects of non-tuberculous mycobacteria on BCG vaccine efficacy: A narrative review. | Ghasemi F, Kardan-Yamchi J, Heidary M, Karami-Zarandi M, Akrami S, Maleki A, Khoshnood S, Kazemian H. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2024.100451 | 2024 | ||
| Mycobacterium vaccae NCTC 11659, a Soil-Derived Bacterium with Stress Resilience Properties, Modulates the Proinflammatory Effects of LPS in Macrophages. | Holbrook EM, Zambrano CA, Wright CTO, Dube EM, Stewart JR, Sanders WJ, Frank MG, MacDonald AS, Reber SO, Lowry CA. | Int J Mol Sci | 10.3390/ijms24065176 | 2023 | ||
| Molecular mechanisms and therapeutic possibilities of short-chain fatty acids in posttraumatic stress disorder patients: a mini-review. | Petakh P, Duve K, Oksenych V, Behzadi P, Kamyshnyi O. | Front Neurosci | 10.3389/fnins.2024.1394953 | 2024 | ||
| Acidophilic methanotrophs: Occurrence, diversity, and possible bioremediation applications. | Hwangbo M, Shao Y, Hatzinger PB, Chu KH. | Environ Microbiol Rep | 10.1111/1758-2229.13156 | 2023 | ||
| Pathogenicity | Evidence that preimmunization with a heat-killed preparation of Mycobacterium vaccae reduces corticotropin-releasing hormone mRNA expression in the extended amygdala in a fear-potentiated startle paradigm. | Loupy KM, Arnold MR, Hassell JE, Lieb MW, Milton LN, Cler KE, Fox JH, Siebler PH, Schmidt D, Noronha SISR, Day HEW, Lowry CA. | Brain Behav Immun | 10.1016/j.bbi.2018.12.015 | 2019 | |
| Therapeutic vaccines for advanced non-small cell lung cancer. | Cortes-Jofre M, Rueda-Etxebarria M, Orillard E, Jimenez Tejero E, Rueda JR. | Cochrane Database Syst Rev | 10.1002/14651858.cd013377.pub2 | 2024 | ||
| Discovery of Antimicrobial Peptides That Can Accelerate Culture Diagnostics of Slow-Growing Mycobacteria Including Mycobacterium tuberculosis. | Hilpert K, Munshi T, Lopez-Perez PM, Sequeira-Garcia J, Hofmann S, Bull TJ. | Microorganisms | 10.3390/microorganisms11092225 | 2023 | ||
| Immunogenicity and Therapeutic Effects of Latency-Associated Genes in a Mycobacterium Tuberculosis Reactivation Mouse Model. | Liang Y, Zhang X, Bai X, Yang Y, Gong W, Wang T, Ling Y, Zhang J, Wang L, Wang J, Li G, Chen Y, Chen X, Wu X. | Hum Gene Ther Methods | 10.1089/hgtb.2018.211 | 2019 | ||
| Mycobacterium vaccae immunization in rats ameliorates features of age-associated microglia activation in the amygdala and hippocampus. | Sanchez K, Darling JS, Kakkar R, Wu SL, Zentay A, Lowry CA, Fonken LK. | Sci Rep | 10.1038/s41598-022-05275-y | 2022 | ||
| Immunization with a heat-killed bacterium, Mycobacterium vaccae NCTC 11659, prevents the development of cortical hyperarousal and a PTSD-like sleep phenotype after sleep disruption and acute stress in mice. | Bowers SJ, Lambert S, He S, Lowry CA, Fleshner M, Wright KP, Turek FW, Vitaterna MH. | Sleep | 10.1093/sleep/zsaa271 | 2021 | ||
| Inhalation of nebulized Mycobacterium vaccae can protect against allergic bronchial asthma in mice by regulating the TGF-beta/Smad signal transduction pathway. | Jiang XH, Li CQ, Feng GY, Luo MJ, Sun QX. | Allergy Asthma Clin Immunol | 10.1186/s13223-020-00456-8 | 2020 | ||
| Production of Salvianic Acid A from l-DOPA via Biocatalytic Cascade Reactions. | Hu KS, Chen CL, Ding HR, Wang TY, Zhu Q, Zhou YC, Chen JM, Mei JQ, Hu S, Huang J, Zhao WR, Mei LH. | Molecules | 10.3390/molecules27186088 | 2022 | ||
| Optimization of a hybrid bacterial/Arabidopsis thaliana fatty acid synthase system II in Saccharomyces cerevisiae. | Pozdniakova TA, Cruz JP, Silva PC, Azevedo F, Parpot P, Domingues MR, Carlquist M, Johansson B. | Metab Eng Commun | 10.1016/j.mec.2023.e00224 | 2023 | ||
| Preimmunization with a heat-killed preparation of Mycobacterium vaccae enhances fear extinction in the fear-potentiated startle paradigm. | Fox JH, Hassell JE, Siebler PH, Arnold MR, Lamb AK, Smith DG, Day HEW, Smith TM, Simmerman EM, Outzen AA, Holmes KS, Brazell CJ, Lowry CA. | Brain Behav Immun | 10.1016/j.bbi.2017.08.014 | 2017 | ||
| The microbiota-gut- hippocampus axis. | Salami M, Soheili M. | Front Neurosci | 10.3389/fnins.2022.1065995 | 2022 | ||
| Tuberculosis vaccines: Opportunities and challenges. | Zhu B, Dockrell HM, Ottenhoff THM, Evans TG, Zhang Y. | Respirology | 10.1111/resp.13245 | 2018 | ||
| Psychophysiological Responses of Humans during Seed-Sowing Activity Using Soil Inoculated with Streptomyces rimosus. | Choi NY, Park SA, Lee YR, Lee CH. | Int J Environ Res Public Health | 10.3390/ijerph192316275 | 2022 | ||
| Effect of Silibinin on Human Pancreatic Lipase Inhibition and Gut Microbiota in Healthy Volunteers: A Randomized Controlled Trial. | Ponce Martinez C, Murcia Garcia E, Perez Sanchez H, Milagro FI, Riezu-Boj JI, Ramos Molina B, Gomez Gallego M, Zamora S, Canavate Cutillas R, Hernandez Morante JJ. | Int J Mol Sci | 10.3390/ijms252312853 | 2024 | ||
| Metabolism | Cometabolic biodegradation of 1,2,3-trichloropropane by propane-oxidizing bacteria. | Wang B, Chu KH. | Chemosphere | 10.1016/j.chemosphere.2016.12.007 | 2017 | |
| Evidence of Mycobacterium bovis DNA in shared water sources at livestock-wildlife-human interfaces in KwaZulu-Natal, South Africa. | Matthews MC, Cooke DM, Kerr TJ, Loxton AG, Warren RM, Ghielmetti G, Streicher EM, Witte CS, Miller MA, Goosen WJ. | Front Vet Sci | 10.3389/fvets.2025.1483162 | 2025 | ||
| A Credibility Assessment Plan for an In Silico Model that Predicts the Dose-Response Relationship of New Tuberculosis Treatments. | Curreli C, Di Salvatore V, Russo G, Pappalardo F, Viceconti M. | Ann Biomed Eng | 10.1007/s10439-022-03078-w | 2023 | ||
| The role of immune modulation and anti-inflammatory agents in the management of prostate cancer: A case report of six patients. | Dalgleish AG, Liu WM. | Oncol Lett | 10.3892/ol.2022.13367 | 2022 | ||
| Genetics | Metabolic Profiling, Antiviral Activity and the Microbiome of Some Mauritian Soft Corals. | Jahajeeah D, Ranghoo-Sanmukhiya M, Schafer G. | Mar Drugs | 10.3390/md21110574 | 2023 | |
| Complete Immunophenotypic Reversal of Chronic Lymphocytic Leukaemia With High Dose Parenteral Methylcobalamin: A Case Report and Brief Review of Cobalamin in Cancer. | Wheatley C. | Cancer Rep (Hoboken) | 10.1002/cnr2.70106 | 2025 | ||
| Effects of Immunization With the Soil-Derived Bacterium Mycobacterium vaccae on Stress Coping Behaviors and Cognitive Performance in a "Two Hit" Stressor Model. | Foxx CL, Heinze JD, Gonzalez A, Vargas F, Baratta MV, Elsayed AI, Stewart JR, Loupy KM, Arnold MR, Flux MC, Sago SA, Siebler PH, Milton LN, Lieb MW, Hassell JE, Smith DG, Lee KAK, Appiah SA, Schaefer EJ, Panitchpakdi M, Sikora NC, Weldon KC, Stamper CE, Schmidt D, Duggan DA, Mengesha YM, Ogbaselassie M, Nguyen KT, Gates CA, Schnabel K, Tran L, Jones JD, Vitaterna MH, Turek FW, Fleshner M, Dorrestein PC, Knight R, Wright KP, Lowry CA. | Front Physiol | 10.3389/fphys.2020.524833 | 2020 | ||
| Reduction of hyperglycemia in STZ-induced diabetic mice by prophylactic treatment with heat-killed Mycobacterium aurum: possible effects on glucose utilization, mitochondrial uncoupling, and oxidative stress in liver and skeletal muscle. | Abdallah F, Bazzi S, Akle C, Bahr GM, Echtay KS. | Front Endocrinol (Lausanne) | 10.3389/fendo.2024.1427058 | 2024 | ||
| Detection of non-tuberculous mycobacterial species using PCR-RFLP analysis in trans-tracheal washes in cattle and buffaloes with respiratory distress. | Slathia P, Narang D, Chandra M, Sharma A, Narang A. | Iran J Vet Res | 2020 | |||
| Immune responses against Mycobacterium tuberculosis-specific proteins PE35 and CFP10 in mice immunized with recombinant Mycobacterium vaccae. | Amoudy HA, Ebrahimi BH, Mustafa AS. | Saudi Med J | 2014 | |||
| Bacterial lysate treatment in allergic disease: A systematic review and meta-analysis. | Li C, Zhou H, Zhang W, Che D. | Pediatr Allergy Immunol | 10.1111/pai.13572 | 2021 | ||
| Chromane Derivatives from Underground Parts of Iris tenuifolia and Their In Vitro Antimicrobial, Cytotoxicity and Antiproliferative Evaluation. | Otgon O, Nadmid S, Paetz C, Dahse HM, Voigt K, Bartram S, Boland W, Dagvadorj E. | Molecules | 10.3390/molecules26216705 | 2021 | ||
| The emerging role of the gut microbiome in posttraumatic stress disorder. | Ke S, Hartmann J, Ressler KJ, Liu YY, Koenen KC. | Brain Behav Immun | 10.1016/j.bbi.2023.09.005 | 2023 | ||
| Enzymology | Penicillium chrysogenum DSOA associated with marine sponge (Tedania anhelans) exhibit antimycobacterial activity. | Visamsetti A, Ramachandran SS, Kandasamy D. | Microbiol Res | 10.1016/j.micres.2015.11.001 | 2016 | |
| Metabolism | Biodegradation of 1,4-dioxane: effects of enzyme inducers and trichloroethylene. | Hand S, Wang B, Chu KH. | Sci Total Environ | 10.1016/j.scitotenv.2015.03.031 | 2015 | |
| Pathogenicity | Effects of Mycobacterium vaccae vaccine in a mouse model of tuberculosis: protective action and differentially expressed genes. | Gong WP, Liang Y, Ling YB, Zhang JX, Yang YR, Wang L, Wang J, Shi YC, Wu XQ. | Mil Med Res | 10.1186/s40779-020-00258-4 | 2020 | |
| Metabolism | Impact of rare codons and the functional coproduction of rate-limiting tRNAs on recombinant protein production in Bacillus megaterium. | Finger C, Gamer M, Klunkelfuss S, Bunk B, Biedendieck R. | Appl Microbiol Biotechnol | 10.1007/s00253-015-6744-5 | 2015 | |
| Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7). | Butov DA, Efremenko YV, Prihoda ND, Zaitzeva SI, Yurchenko LV, Sokolenko NI, Butova TS, Stepanenko AL, Kutsyna GA, Jirathitikal V, Bourinbaiar AS. | Immunotherapy | 10.2217/imt.13.110 | 2013 | ||
| Enzymology | Expanding the Landscape of Dual Action Antifolate Antibacterials through 2,4-Diamino-1,6-dihydro-1,3,5-triazines. | Georgiades JD, Berkovich DA, McKee SR, Smith AR, Sankaran B, Flentie KN, Castaneda CH, Grohmann DG, Rohatgi R, Lasky C, Mason TA, Champine JE, Miller PA, Mollmann U, Moraski GC, Franzblau SG, Miller MJ, Stallings CL, Jez JM, Hathaway BA, Wencewicz TA. | ACS Infect Dis | 10.1021/acsinfecdis.4c00768 | 2025 | |
| Ingestion of Mycobacterium vaccae decreases anxiety-related behavior and improves learning in mice. | Matthews DM, Jenks SM. | Behav Processes | 10.1016/j.beproc.2013.02.007 | 2013 | ||
| Analysis of the immunomodulatory properties of two heat-killed mycobacterial preparations in a human whole blood model. | Bazzi S, Modjtahedi H, Mudan S, Akle C, Bahr GM. | Immunobiology | 10.1016/j.imbio.2015.07.015 | 2015 | ||
| Prenylated Isoflavanones with Antimicrobial Potential from the Root Bark of Dalbergia melanoxylon. | Chalo DM, Franke K, Nchiozem-Ngnitedem VA, Kakudidi E, Origa-Oryem H, Namukobe J, Kloss F, Yenesew A, Wessjohann LA. | Metabolites | 10.3390/metabo13060678 | 2023 | ||
| Metabolism | Altered redox status in Escherichia coli cells enhances pyruvate production in pH-adjusting culture with a fermenter. | Ojima Y, Matsuo N, Suparman A, Suryadarma P, Taya M. | Bioprocess Biosyst Eng | 10.1007/s00449-013-1002-7 | 2014 | |
| Metabolism | Improvement of the soy formate dehydrogenase properties by rational design. | Kargov IS, Kleimenov SY, Savin SS, Tishkov VI, Alekseeva AA. | Protein Eng Des Sel | 10.1093/protein/gzv007 | 2015 | |
| Pathogenicity | The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae. | Phelan J, Maitra A, McNerney R, Nair M, Gupta A, Coll F, Pain A, Bhakta S, Clark TG. | Int J Mycobacteriol | 10.1016/j.ijmyco.2015.05.001 | 2015 | |
| Metabolism | Recovery of electric energy from formate by using a recombinant strain of Escherichia coli. | Ojima Y, Kawata T, Matsuo N, Nishinoue Y, Taya M. | Bioprocess Biosyst Eng | 10.1007/s00449-014-1179-4 | 2014 | |
| Preclinical models of maternal asthma and progeny outcomes: a scoping review. | Robinson JL, Gatford KL, Bailey DN, Roff AJ, Clifton VL, Morrison JL, Stark MJ. | Eur Respir Rev | 10.1183/16000617.0174-2023 | 2024 | ||
| Phylogeny | Prevalence and distribution of non-tuberculous mycobacteria (NTM) in cattle, African buffaloes (Syncerus caffer) and their environments in South Africa. | Gcebe N, Rutten V, Gey van Pittius NC, Michel A. | Transbound Emerg Dis | 10.1111/tbed.12133 | 2013 | |
| Immunology of atopic dermatitis: novel insights into mechanisms and immunomodulatory therapies. | Harskamp CT, Armstrong AW. | Semin Cutan Med Surg | 10.12788/j.sder.0018 | 2013 | ||
| In silico design of Mycobacterium tuberculosis multi-epitope adhesin protein vaccines. | Pillay K, Chiliza TE, Senzani S, Pillay B, Pillay M. | Heliyon | 10.1016/j.heliyon.2024.e37536 | 2024 | ||
| Therapeutic and Prophylactic Effects of Amphotericin B Liposomes on Chronic Social Defeat Stress-Induced Behavioral Abnormalities in Mice. | Lu J, Huang C, Lu Q, Lu X. | Front Pharmacol | 10.3389/fphar.2022.918177 | 2022 | ||
| Copper(ii) complexes with terpene derivatives of ethylenediamine: synthesis, and antibacterial, antifungal and antioxidant activity. | Gur'eva YA, Zalevskaya OA, Shevchenko OG, Slepukhin PA, Makarov VA, Kuchin AV. | RSC Adv | 10.1039/d2ra00223j | 2022 | ||
| Correlation between systemic allergen desensitisation and long-term asthma protection in mice following intravenous administration of the live tuberculosis vaccine MTBVAC. | Calvo S, Rodrigo-Munoz JM, Tarancon R, Uranga S, Martin C, Pozo VD, Aguilo N. | EBioMedicine | 10.1016/j.ebiom.2024.105272 | 2024 | ||
| Adjunctive therapy of Mycobacterium vaccae vaccine in the treatment of multidrug-resistant tuberculosis: A systematic review and meta-analysis. | Weng H, Huang JY, Meng XY, Li S, Zhang GQ. | Biomed Rep | 10.3892/br.2016.624 | 2016 | ||
| Metabolism | 6:2 Fluorotelomer alcohol (6:2 FTOH) biodegradation by multiple microbial species under different physiological conditions. | Kim MH, Wang N, Chu KH. | Appl Microbiol Biotechnol | 10.1007/s00253-013-5131-3 | 2014 | |
| Pathogenicity | Aerosol inhalation of Mycobacterium bovis can reduce the Th2 dominant immune response induced by ovalbumin sensitization. | Chen X, Jiang X, Lu Y, Yao Y, Lu J, Zhi Q, Lai L, Liang J, Li C. | Am J Transl Res | 2022 | ||
| Metabolism | Effects of growth substrate on triclosan biodegradation potential of oxygenase-expressing bacteria. | Lee DG, Chu KH. | Chemosphere | 10.1016/j.chemosphere.2013.06.069 | 2013 | |
| Immunological basis for the introduction of immunotherapy with Mycobacterium vaccae into the routine treatment of TB. | Dlugovitzky D, Stanford C, Stanford J. | Immunotherapy | 10.2217/imt.11.6 | 2011 | ||
| Metabolism | The Mycobacteriophage Ms6 LysB N-Terminus Displays Peptidoglycan Binding Affinity. | Gigante AM, Olivenca F, Catalao MJ, Leandro P, Moniz-Pereira J, Filipe SR, Pimentel M. | Viruses | 10.3390/v13071377 | 2021 | |
| Endofungal bacteria boost anthelminthic host protection with the biosurfactant symbiosin. | Buttner H, Pidot SJ, Scherlach K, Hertweck C. | Chem Sci | 10.1039/d2sc04167g | 2022 | ||
| Metabolism | Mycobacterium vaccae Nebulization Can Protect against Asthma in Balb/c Mice by Regulating Th9 Expression. | Li C, Jiang X, Luo M, Feng G, Sun Q, Chen Y. | PLoS One | 10.1371/journal.pone.0161164 | 2016 | |
| Molecular networking and computational NMR analyses uncover six polyketide-terpene hybrids from termite-associated Xylaria isolates. | Lee SR, Dayras M, Fricke J, Guo H, Balluff S, Schalk F, Yu JS, Jeong SY, Morgenstern B, Slippers B, Beemelmanns C, Kim KH. | Commun Chem | 10.1038/s42004-024-01210-6 | 2024 | ||
| Accumulation of pyruvate by changing the redox status in Escherichia coli | Ojima Y, Suryadarma P, Tsuchida K, Taya M. | Biotechnol Lett | 2012 | |||
| Preventive effects of Mycobacterium vaccae on HIV-associated tuberculosis: a systematic review. | Chen Q, Yang X, Li Y, He X, Ma X, Ma L, Guo Z, Li L. | J Evid Based Med | 10.1111/j.1756-5391.2011.01121.x | 2011 | ||
| Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month. | Bourinbaiar AS, Batbold U, Efremenko Y, Sanjagdorj M, Butov D, Damdinpurev N, Grinishina E, Mijiddorj O, Kovolev M, Baasanjav K, Butova T, Prihoda N, Batbold O, Yurchenko L, Tseveendorj A, Arzhanova O, Chunt E, Stepanenko H, Sokolenko N, Makeeva N, Tarakanovskaya M, Borisova V, Reid A, Kalashnikov V, Nyasulu P, Prabowo SA, Jirathitikal V, Bain AI, Stanford C, Stanford J. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2019.100141 | 2020 | ||
| The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer. | Peters BA, Pass HI, Burk RD, Xue X, Goparaju C, Sollecito CC, Grassi E, Segal LN, Tsay JJ, Hayes RB, Ahn J. | Genome Med | 10.1186/s13073-022-01126-7 | 2022 | ||
| Immune response of BALB/c mice against an experimental vaccine of Alum precipitated autoclaved Leishmania major (Alum-ALM) mixed with BCG or Mycobacterium vaccae. | Nateghi Rostami M, Keshavarz H, Khamesipour A. | Trop Biomed | 2010 | |||
| "Sentinel or accomplice": gut microbiota and microglia crosstalk in disorders of gut-brain interaction. | Zheng H, Zhang C, Zhang J, Duan L. | Protein Cell | 10.1093/procel/pwad020 | 2023 | ||
| Metabolism | Asymmetric Whole-Cell Bio-Reductions of (R)-Carvone Using Optimized Ene Reductases. | Mahler C, Burger C, Kratzl F, Weuster-Botz D, Castiglione K. | Molecules | 10.3390/molecules24142550 | 2019 | |
| Immunotherapy for tuberculosis: what's the better choice? | Guo S, Zhao J. | Front Biosci (Landmark Ed) | 10.2741/4079 | 2012 | ||
| Phylogeny | Complete genome sequence of Mycobacterium vaccae type strain ATCC 25954. | Ho YS, Adroub SA, Abadi M, Al Alwan B, Alkhateeb R, Gao G, Ragab A, Ali S, van Soolingen D, Bitter W, Pain A, Abdallah AM. | J Bacteriol | 10.1128/jb.01462-12 | 2012 | |
| Metabolism | Pathways underlying afferent signaling of bronchopulmonary immune activation to the central nervous system. | Hale MW, Rook GA, Lowry CA. | Chem Immunol Allergy | 10.1159/000336505 | 2012 | |
| Immunotherapy with oral, heat-killed, Mycobacterium vaccae in patients with moderate to advanced pulmonary tuberculosis. | Dlugovitzky D, Notario R, Martinel-Lamas D, Fiorenza G, Farroni M, Bogue C, Stanford C, Stanford J. | Immunotherapy | 10.2217/imt.09.90 | 2010 | ||
| Metabolism | Accumulation of pyruvate by changing the redox status in Escherichia coli. | Ojima Y, Suryadarma P, Tsuchida K, Taya M. | Biotechnol Lett | 10.1007/s10529-011-0842-y | 2012 | |
| Metabolism | Multi-enzymatic one-pot reduction of dehydrocholic acid to 12-keto-ursodeoxycholic acid with whole-cell biocatalysts. | Sun B, Kantzow C, Bresch S, Castiglione K, Weuster-Botz D. | Biotechnol Bioeng | 10.1002/bit.24606 | 2013 | |
| Metabolism | MnoSR removal in Mycobacterium smegmatis triggers broad transcriptional response to 1,3-propanediol and glucose as sole carbon sources. | Plocinska R, Strus K, Korycka-Machala M, Plocinski P, Kuziola M, Zaczek A, Slomka M, Dziadek J. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1427829 | 2024 | |
| Pathogenicity | Potential for immunotherapy with heat-killed Mycobacterium vaccae in respiratory medicine. | Stanford J, Stanford C, Dlugovitzky D, Fiorenza G, Martinel-Lamas D, Selenscig D, Bogue C. | Immunotherapy | 10.2217/imt.09.62 | 2009 | |
| Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis. | Liang Y, Wu X, Zhang J, Xiao L, Yang Y, Bai X, Yu Q, Li Z, Bi L, Li N, Wu X. | FEMS Immunol Med Microbiol | 10.1111/1574-695x.12008 | 2012 | ||
| A New Adjuvant MTOM Mediates Mycobacterium tuberculosis Subunit Vaccine to Enhance Th1-Type T Cell Immune Responses and IL-2+ T Cells. | Yu Q, Wang X, Fan X. | Front Immunol | 10.3389/fimmu.2017.00585 | 2017 | ||
| Mycobacterium vaccae vaccine to prevent tuberculosis in high risk people: a meta-analysis. | Yang XY, Chen QF, Cui XH, Yu Y, Li YP. | J Infect | 10.1016/j.jinf.2010.02.005 | 2010 | ||
| Metabolism | Novel whole-cell biocatalysts with recombinant hydroxysteroid dehydrogenases for the asymmetric reduction of dehydrocholic acid. | Braun M, Sun B, Anselment B, Weuster-Botz D. | Appl Microbiol Biotechnol | 10.1007/s00253-012-4072-6 | 2012 | |
| Environmental behavior and human health risks of PFAS: occurrence, toxicity, and the state-of-the-art removal approaches. | Narasimhappa P, Singh S, Varshney R, Chauhan V, Kour R, Ramamurthy PC, Shehata N. | RSC Adv | 10.1039/d5ra07672b | 2025 | ||
| Mycobacterium vaccae induces a strong Th1 response that subsequently declines in C57BL/6 mice. | Zhang L, Jiang Y, Cui Z, Yang W, Yue L, Ma Y, Shi S, Wang C, Wang C, Qian A. | J Vet Sci | 10.4142/jvs.2016.17.4.505 | 2016 | ||
| Metabolism | Engineering of formate dehydrogenase: synergistic effect of mutations affecting cofactor specificity and chemical stability. | Hoelsch K, Suhrer I, Heusel M, Weuster-Botz D. | Appl Microbiol Biotechnol | 10.1007/s00253-012-4142-9 | 2013 | |
| Robustness of Significant Dichotomous Outcomes in Randomized Controlled Trials in the Treatment of Patients with COVID-19: A Systematic Analysis. | Liu Q, Chen H, Gao Y, Zhu C. | Intensive Care Res | 10.1007/s44231-022-00027-y | 2023 | ||
| The Genus Iris Tourn. ex L.: Updates on Botany, Cultivation, Novel Niches and Impactful Applications. | Crisan I. | Plants (Basel) | 10.3390/plants14182870 | 2025 | ||
| Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis. | Huang CY, Hsieh WY. | Hum Vaccin Immunother | 10.1080/21645515.2017.1335374 | 2017 | ||
| [Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis]. | Bai YL, Xue Y, Wang LM, Fan AL, Zhang W, Kang J, He JJ, Xu ZK. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2009 | |||
| Metabolism | Advances and perspectives of using stable isotope probing (SIP)-based technologies in contaminant biodegradation. | Kim J, Hwangbo M, Shih CH, Chu KH. | Water Res X | 10.1016/j.wroa.2023.100187 | 2023 | |
| Biotransformation of Phytosterols into Androstenedione-A Technological Prospecting Study. | Nunes VO, Vanzellotti NC, Fraga JL, Pessoa FLP, Ferreira TF, Amaral PFF. | Molecules | 10.3390/molecules27103164 | 2022 | ||
| Effect of a Mycobacterium vaccae derivative on paediatric atopic dermatitis: a randomized, controlled trial. | Brothers S, Asher MI, Jaksic M, Stewart AW. | Clin Exp Dermatol | 10.1111/j.1365-2230.2008.03153.x | 2009 | ||
| Mycobacterium vaccae immunization protects aged rats from surgery-elicited neuroinflammation and cognitive dysfunction. | Fonken LK, Frank MG, D'Angelo HM, Heinze JD, Watkins LR, Lowry CA, Maier SF. | Neurobiol Aging | 10.1016/j.neurobiolaging.2018.07.012 | 2018 | ||
| Ecological Niche-Inspired Genome Mining Leads to the Discovery of Crop-Protecting Nonribosomal Lipopeptides Featuring a Transient Amino Acid Building Block. | Gotze S, Vij R, Burow K, Thome N, Urbat L, Schlosser N, Pflanze S, Muller R, Hansch VG, Schlabach K, Fazlikhani L, Walther G, Dahse HM, Regestein L, Brunke S, Hube B, Hertweck C, Franken P, Stallforth P. | J Am Chem Soc | 10.1021/jacs.2c11107 | 2023 | ||
| Chronic Mycobacterium avium infection differentially affects the cytokine expression profile of three mouse strains, but has no effect on behavior. | Roque S, de Sa-Calcada D, Cerqueira-Rodrigues B, Monteiro S, Guerreiro SG, Palha JA, Correia-Neves M. | Sci Rep | 10.1038/s41598-023-33121-2 | 2023 | ||
| Enzymology | The Antimicrobial and Immunomodulatory Function of RNase 7 in Skin. | Rademacher F, Dreyer S, Kopfnagel V, Glaser R, Werfel T, Harder J. | Front Immunol | 10.3389/fimmu.2019.02553 | 2019 | |
| Psychophysiological and Metabolomics Responses of Adults during Horticultural Activities Using Soil Inoculated with Streptomyces rimosus: A Pilot Study. | Kim SO, Kim MJ, Choi NY, Kim JH, Oh MS, Lee CH, Park SA. | Int J Environ Res Public Health | 10.3390/ijerph191912901 | 2022 | ||
| Metabolism | Enantioselective reduction of prochiral ketones by engineered bifunctional fusion proteins. | Holsch K, Weuster-Botz D. | Biotechnol Appl Biochem | 10.1042/ba20100143 | 2010 | |
| Metabolism | Immunization with Mycobacterium vaccae induces an anti-inflammatory milieu in the CNS: Attenuation of stress-induced microglial priming, alarmins and anxiety-like behavior. | Frank MG, Fonken LK, Dolzani SD, Annis JL, Siebler PH, Schmidt D, Watkins LR, Maier SF, Lowry CA. | Brain Behav Immun | 10.1016/j.bbi.2018.05.020 | 2018 | |
| Treatment with Mycobacterium vaccae ameliorates airway histopathology in a murine model of asthma. | Yazi D, Akkoc T, Yesil O, Ozdemir C, Aydogan M, Koksalan K, Bahceciler NN, Barlan IB. | Allergy Asthma Proc | 10.2500/aap2008.29.3082 | 2008 | ||
| Immunotherapy for the prevention of myointimal hyperplasia after experimental balloon injury of the rat carotid artery. | Hansrani M, Stanford J, McIntyre G, Bottasso O, Stansby G. | Angiology | 10.1177/0003319710366128 | 2010 | ||
| Metabolism | The composition of cell wall skeleton and outermost lipids of Mycobacterium vaccae is modified by ethambutol treatment. | Rumijowska-Galewicz A, Korycka-Machala M, Lisowska K, Dziadek J. | Pol J Microbiol | 2008 | ||
| Microscopic evaluation of renal changes in experimental canine visceral leishmaniosis after chemo- and immunotherapy. | Sayari M, Avizeh R, Barati F. | Pak J Biol Sci | 10.3923/pjbs.2008.1630.1633 | 2008 | ||
| Role of Mycobacterium vaccae in the protection induced by first generation Leishmania vaccine against murine model of leishmaniasis. | Keshavarz Valian H, Khoshabe Abdollah Kenedy L, Nateghi Rostami M, Miramin Mohammadi A, Khamesipour A. | Parasitol Res | 10.1007/s00436-008-0921-8 | 2008 | ||
| Enzymology | Effect of Additional Amino Acid Replacements on the Properties of Multi-point Mutant Bacterial Formate Dehyderogenase PseFDH SM4S. | Pometun AA, Parshin PD, Galanicheva NP, Shaposhnikov LA, Atroshenko DL, Pometun EV, Burmakin VV, Kleymenov SY, Savin SS, Tishkov VI. | Acta Naturae | 10.32607/actanaturae.11665 | 2022 | |
| An Overview of Immunotherapeutic Approaches Against Canine Visceral Leishmaniasis: What Has Been Tested on Dogs and a New Perspective on Improving Treatment Efficacy. | Goncalves AAM, Leite JC, Resende LA, Mariano RMDS, Silveira P, Melo-Junior OAO, Ribeiro HS, de Oliveira DS, Soares DF, Santos TAP, Marques AF, Galdino AS, Martins-Filho OA, Dutra WO, da Silveira-Lemos D, Giunchetti RC. | Front Cell Infect Microbiol | 10.3389/fcimb.2019.00427 | 2019 | ||
| Pathogenicity | Treatment with a heat-killed preparation of Mycobacterium vaccae after fear conditioning enhances fear extinction in the fear-potentiated startle paradigm. | Hassell JE, Fox JH, Arnold MR, Siebler PH, Lieb MW, Schmidt D, Spratt EJ, Smith TM, Nguyen KT, Gates CA, Holmes KS, Schnabel KS, Loupy KM, Erber M, Lowry CA. | Brain Behav Immun | 10.1016/j.bbi.2019.06.008 | 2019 | |
| A Novel Microfluidic Dielectrophoresis Technology to Enable Rapid Diagnosis of Mycobacteria tuberculosis in Clinical Samples. | Moore CM, Dhillon J, Flynn R, Gizynski K, Adams C, Morgan G, McGurk D, Boada E, Shabestary S, Peat J, O'Halloran J, Stoker NG, Butcher PD, Murton H. | J Mol Diagn | 10.1016/j.jmoldx.2023.04.005 | 2023 | ||
| Metabolism | Functional characterization of propane-enhanced N-nitrosodimethylamine degradation by two actinomycetales. | Sharp JO, Sales CM, Alvarez-Cohen L. | Biotechnol Bioeng | 10.1002/bit.22899 | 2010 | |
| The effects of Mycobacteria vaccae derivative on allergen-specific responses in children with atopic dermatitis. | Dunstan JA, Brothers S, Bauer J, Hodder M, Jaksic MM, Asher MI, Prescott SL. | Clin Exp Immunol | 10.1111/j.1365-2249.2011.04371.x | 2011 | ||
| Biologic therapy for systemic sclerosis: a systematic review. | Phumethum V, Jamal S, Johnson SR. | J Rheumatol | 10.3899/jrheum.100361 | 2011 | ||
| Metabolism | Mycobacterium vaccae immunization to OVA sensitized pregnant BALB/c mice suppressed placental and postnatal IL-5 and inducing IFN-gamma secretion. | Akkoc T, Eifan AO, Ozdemir C, Yazi D, Yesil O, Bahceciler NN, Barlan IB. | Immunopharmacol Immunotoxicol | 10.1080/08923970701812159 | 2008 | |
| Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung. | Stanford JL, Stanford CA, O'Brien ME, Grange JM. | Eur J Cancer | 10.1016/j.ejca.2007.08.021 | 2008 | ||
| Pathogenicity | Identification and characterization of a novel anti-inflammatory lipid isolated from Mycobacterium vaccae, a soil-derived bacterium with immunoregulatory and stress resilience properties. | Smith DG, Martinelli R, Besra GS, Illarionov PA, Szatmari I, Brazda P, Allen MA, Xu W, Wang X, Nagy L, Dowell RD, Rook GAW, Rosa Brunet L, Lowry CA. | Psychopharmacology (Berl) | 10.1007/s00213-019-05253-9 | 2019 | |
| An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancer. | Patel PM, Sim S, O'Donnell DO, Protheroe A, Beirne D, Stanley A, Tourani JM, Khayat D, Hancock B, Vasey P, Dalgleish A, Johnston C, Banks RE, Selby PJ. | Eur J Cancer | 10.1016/j.ejca.2007.11.003 | 2008 | ||
| Intradermal injection of heat-killed Mycobacterium vaccae in dogs with atopic dermatitis: a multicentre pilot study. | Ricklin Gutzwiller ME, Reist M, Peel JE, Seewald W, Brunet LR, Roosje PJ. | Vet Dermatol | 10.1111/j.1365-3164.2007.00579.x | 2007 | ||
| Metabolism | Expression, purification, and characterization of soluble RpfD with high bioactivity as a recombinant protein in Mycobacterium vaccae. | Gao H, Bai Y, Xue Y, Wang L, Fan A, Ding X, Xu Z. | Protein Expr Purif | 10.1016/j.pep.2007.05.002 | 2007 | |
| Pathogenicity | Neuroinflammation and Schizophrenia: New Therapeutic Strategies through Psychobiotics, Nanotechnology, and Artificial Intelligence (AI). | Mosquera FEC, Guevara-Montoya MC, Serna-Ramirez V, Liscano Y. | J Pers Med | 10.3390/jpm14040391 | 2024 | |
| Vaccine Potential of Mycobacterial Antigens against Asthma. | Mustafa AS. | Med Princ Pract | 10.1159/000508719 | 2020 | ||
| Proteogenomic Analysis and Discovery of Immune Antigens in Mycobacterium vaccae. | Zheng J, Chen L, Liu L, Li H, Liu B, Zheng D, Liu T, Dong J, Sun L, Zhu Y, Yang J, Zhang X, Jin Q. | Mol Cell Proteomics | 10.1074/mcp.m116.065813 | 2017 | ||
| M. tuberculosis AlkX Encoded by rv3249c Regulates a Conserved Alkane Hydroxylase System That Is Important for Replication in Macrophages and Biofilm Formation. | Stokas H, Rhodes HL, Simmons MB, Zhang R, Wright CC, Purdy GE. | Microbiol Spectr | 10.1128/spectrum.01969-22 | 2022 | ||
| Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. | Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP. | Thorax | 10.1136/thx.2007.087999 | 2008 | ||
| Long-term modulatory effect of Mycobacterium vaccae treatment on histopathologic changes in a murine model of asthma. | Yazi D, Akkoc T, Ozdemir C, Yesil O, Aydogan M, Sancak R, Bahceciler NN, Barlan IB. | Ann Allergy Asthma Immunol | 10.1016/s1081-1206(10)60738-7 | 2007 | ||
| Immunotherapy for malignant melanoma--tracing Ariadne's thread through the labyrinth. | Grange JM, Krone B, Stanford JL. | Eur J Cancer | 10.1016/j.ejca.2009.05.002 | 2009 | ||
| Preventive effects of Mycobacterium tuberculosis DNA vaccines on the mouse model with latent tuberculosis infection. | Liang Y, Li X, Yang Y, Xiao L, Liang Y, Mi J, Xue Y, Gong W, Wang L, Wang J, Zhang J, Shi Y, Peng B, Chen X, Zhao W, Wu X. | Front Immunol | 10.3389/fimmu.2023.1110843 | 2023 | ||
| The use of mycobacterial adjuvant-based agents for immunotherapy of cancer. | Grange JM, Bottasso O, Stanford CA, Stanford JL. | Vaccine | 10.1016/j.vaccine.2008.06.092 | 2008 | ||
| Metabolism | The production of a new extracellular putative long-chain saturated polyester by smooth variants of Mycobacterium vaccae interferes with Th1-cytokine production. | Rodriguez-Guell E, Agusti G, Corominas M, Cardona PJ, Casals I, Parella T, Sempere MA, Luquin M, Julian E. | Antonie Van Leeuwenhoek | 10.1007/s10482-006-9062-1 | 2006 | |
| Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial. | Berth-Jones J, Arkwright PD, Marasovic D, Savani N, Aldridge CR, Leech SN, Morgan C, Clark SM, Ogilvie S, Chopra S, Harper JI, Smith CH, Rook GA, Friedmann PS. | Clin Exp Allergy | 10.1111/j.1365-2222.2006.02558.x | 2006 | ||
| The common mycobacterial antigens and their importance in the treatment of disease. | Stanford J, Stanford C, Stansby G, Bottasso O, Bahr G, Grange J. | Curr Pharm Des | 10.2174/138161209787846838 | 2009 | ||
| Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in Mice. | Chen S, Quan DH, Wang XT, Sandford S, Kirman JR, Britton WJ, Rehm BHA. | Nanomaterials (Basel) | 10.3390/nano11082060 | 2021 | ||
| Proteome | Proteome Profile Changes Induced by Heterologous Overexpression of Mycobacterium tuberculosis-Derived Antigens PstS-1 (Rv0934) and Ag85B (Rv1886c) in Mycobacterium microti. | Garcia-Ruiz V, Orduna P, Castillo-Rodal AI, Flores-Rodriguez TJ, Lopez-Vidal Y. | Biomolecules | 10.3390/biom12121836 | 2022 | |
| Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis. | Dlugovitzky D, Fiorenza G, Farroni M, Bogue C, Stanford C, Stanford J. | Respir Med | 10.1016/j.rmed.2005.09.026 | 2006 | ||
| A Novel Rapidly Growing Mycobacterium Species Causing an Abdominal Cerebrospinal Fluid Pseudocyst Infection. | Hussain CK, de Man TJ, Toney NC, Kamboj K, Balada-Llasat JM, Wang SH. | Open Forum Infect Dis | 10.1093/ofid/ofw146 | 2016 | ||
| The bacterial community of childcare centers: potential implications for microbial dispersal and child exposure. | Beasley DE, Monsur M, Hu J, Dunn RR, Madden AA. | Environ Microbiome | 10.1186/s40793-022-00404-6 | 2022 | ||
| Comparative genome analyses of mycobacteria give better insights into their evolution. | Wee WY, Dutta A, Choo SW. | PLoS One | 10.1371/journal.pone.0172831 | 2017 | ||
| Phytotoxicity of Schiekia timida Seed Extracts, a Mixture of Phenylphenalenones. | Ocampos FMM, de Souza AJB, Antar GM, Wouters FC, Colnago LA. | Molecules | 10.3390/molecules26144197 | 2021 | ||
| Metabolism | Epicoccarines A, B and epipyridone: tetramic acids and pyridone alkaloids from an Epicoccum sp. associated with the tree fungus Pholiota squarrosa. | Kemami Wangun HV, Hertweck C. | Org Biomol Chem | 10.1039/b702378b | 2007 | |
| Resilience and the Gut Microbiome: Insights from Chronically Socially Stressed Wild-Type Mice. | Dos Santos Guilherme M, Valeri F, Winter J, Muller MB, Schwiertz A, Endres K. | Microorganisms | 10.3390/microorganisms10061077 | 2022 | ||
| Pathogenicity | Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7). | Efremenko YV, Butov DA, Prihoda ND, Zaitzeva SI, Yurchenko LV, Sokolenko NI, Butova TS, Stepanenko AL, Kutsyna GA, Jirathitikal V, Bourinbaiar AS. | Hum Vaccin Immunother | 10.4161/hv.25280 | 2013 | |
| Toward Characterizing Environmental Sources of Non-tuberculous Mycobacteria (NTM) at the Species Level: A Tutorial Review of NTM Phylogeny and Phylogenetic Classification. | Zhang L, Lin TY, Liu WT, Ling F. | ACS Environ Au | 10.1021/acsenvironau.3c00074 | 2024 | ||
| Intragastric administration of Mycobacterium vaccae inhibits severe pulmonary allergic inflammation in a mouse model. | Hunt JR, Martinelli R, Adams VC, Rook GA, Brunet LR. | Clin Exp Allergy | 10.1111/j.1365-2222.2005.02239.x | 2005 | ||
| Mycobacterium vaccae reduces scratching behavior but not the rash in NC mice with eczema: a randomized, blinded, placebo-controlled trial. | Arkwright PD, Fujisawa C, Tanaka A, Matsuda H. | J Invest Dermatol | 10.1111/j.0022-202x.2004.23561.x | 2005 | ||
| Vaccine against tuberculosis: what's new? | Montagnani C, Chiappini E, Galli L, de Martino M. | BMC Infect Dis | 10.1186/1471-2334-14-s1-s2 | 2014 | ||
| Long-term survival and outcome of patients originally given Mycobacterium vaccae for metastatic malignant melanoma. | Cananzi FC, Mudan S, Dunne M, Belonwu N, Dalgleish AG. | Hum Vaccin Immunother | 10.4161/hv.25618 | 2013 | ||
| Potential of Mycobacterium tuberculosis chorismate mutase (Rv1885c) as a novel TLR4-mediated adjuvant for dendritic cell-based cancer immunotherapy. | Jeong H, Lee SY, Seo H, Kim DH, Lee D, Kim BJ. | Oncoimmunology | 10.1080/2162402x.2021.2023340 | 2022 | ||
| Effect of Mycobacterium vaccae on cytokine responses in children with atopic dermatitis. | Hadley EA, Smillie FI, Turner MA, Custovic A, Woodcock A, Arkwright PD. | Clin Exp Immunol | 10.1111/j.1365-2249.2005.02743.x | 2005 | ||
| Metabolism | Pathway, inhibition and regulation of methyl tertiary butyl ether oxidation in a filamentous fungus, Graphium sp. | Skinner KM, Martinez-Prado A, Hyman MR, Williamson KJ, Ciuffetti LM. | Appl Microbiol Biotechnol | 10.1007/s00253-007-1268-2 | 2008 | |
| Population differences in death rates in HIV-positive patients with tuberculosis. | Ciglenecki I, Glynn JR, Mwinga A, Ngwira B, Zumla A, Fine PE, Nunn A. | Int J Tuberc Lung Dis | 2007 | |||
| A pilot study of SRL 172 (killed Mycobacterium vaccae) in healthy chronic hepatitis B carriers and hepatitis B vaccine non-responders. | Goldwater PN. | Hum Vaccin | 10.4161/hv.2.1.2436 | 2006 | ||
| Tuberculosis in people with HIV. | Payne B, Bellamy R. | BMJ Clin Evid | 2007 | |||
| Mycobacterium vaccae immunotherapy for treating tuberculosis. | de Bruyn G, Garner P. | Cochrane Database Syst Rev | 10.1002/14651858.cd001166 | 2003 | ||
| Characterization of co-metabolic biodegradation of methyl tert-butyl ether by a Acinetobacter sp. strain. | Li S, Wang D, Du D, Qian K, Yan W. | RSC Adv | 10.1039/c9ra09507a | 2019 | ||
| Diastereoselective synthesis of cyclic tetrapeptide pseudoxylallemycin A illuminates the impact of base during macrolactamization. | Fumo VM, Roberts RC, Zhang J, O'Reilly MC. | Org Biomol Chem | 10.1039/d2ob02126a | 2023 | ||
| Metabolism | Expression of glf Z.m. increases D-mannitol formation in whole cell biotransformation with resting cells of Corynebacterium glutamicum. | Baumchen C, Bringer-Meyer S. | Appl Microbiol Biotechnol | 10.1007/s00253-007-0987-8 | 2007 | |
| Effect of Mycobacterium vaccae (SRL172) immunotherapy on radiographic healing in tuberculosis. | Johnson JL, Nunn AJ, Fourie PB, Ormerod LP, Mugerwa RD, Mwinga A, Chintu C, Ngwira B, Onyebujoh P, Zumla A. | Int J Tuberc Lung Dis | 2004 | |||
| Metabolism | Acute Administration of the Nonpathogenic, Saprophytic Bacterium, Mycobacterium vaccae, Induces Activation of Serotonergic Neurons in the Dorsal Raphe Nucleus and Antidepressant-Like Behavior in Association with Mild Hypothermia. | Siebler PH, Heinze JD, Kienzle DM, Hale MW, Lukkes JL, Donner NC, Kopelman JM, Rodriguez OA, Lowry CA. | Cell Mol Neurobiol | 10.1007/s10571-017-0564-3 | 2018 | |
| [Robert Koch was right. Towards a new interpretation of tuberculin therapy]. | Cardona PJ. | Enferm Infecc Microbiol Clin | 10.1157/13089694 | 2006 | ||
| SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. | O'Brien ME, Anderson H, Kaukel E, O'Byrne K, Pawlicki M, Von Pawel J, Reck M, SR-ON-12 Study Group. | Ann Oncol | 10.1093/annonc/mdh220 | 2004 | ||
| Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected. | Cheng J, Zhou L, Wang H. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1296295 | 2024 | ||
| Metabolism | D-mannitol production by resting state whole cell biotrans-formation of D-fructose by heterologous mannitol and formate dehydrogenase gene expression in Bacillus megaterium. | Baumchen C, Roth AH, Biedendieck R, Malten M, Follmann M, Sahm H, Bringer-Meyer S, Jahn D. | Biotechnol J | 10.1002/biot.200700055 | 2007 | |
| Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity. | Dalgleish AG, Mudan S, Fusi A. | J Transl Med | 10.1186/s12967-018-1602-8 | 2018 | ||
| Non-canonical two-step biosynthesis of anti-oomycete indole alkaloids in Kickxellales. | Rassbach J, Hilsberg N, Haensch VG, Dorner S, Gressler J, Sonnabend R, Semm C, Voigt K, Hertweck C, Gressler M. | Fungal Biol Biotechnol | 10.1186/s40694-023-00166-x | 2023 | ||
| Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic mice. | Adams VC, Hunt JRF, Martinelli R, Palmer R, Rook GAW, Brunet LR. | Eur J Immunol | 10.1002/eji.200324659 | 2004 | ||
| A Single-Dose Intramuscular Nanoparticle Vaccine With or Without Prior Intrauterine Priming Triggers Specific Uterine and Colostral Mucosal Antibodies and Systemic Immunity in Gilts but Not Passive Protection for Suckling Piglets. | Choudhary P, Khajavinia A, Mohammadi R, Ng SH, Berube N, Yalamati D, Haddadi A, Wilson HL. | Front Vet Sci | 10.3389/fvets.2022.931232 | 2022 | ||
| [Construction and identification of the E.coli-BCG shuttle vector expressing lipoprotein Der p2 on cell wall of mycobacterium vaccae]. | Shi JR, Li Y, Qi HW, Li BH, Fan XL. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2003 | |||
| Pathogenicity | Anti-bacterial activities and phytochemical screening of extracts of different parts of Thalictrum rhynchocarpum. | Mayeku PW, Hassanali A, Kiremire BT, Odalo JO, Hertweck C. | Afr J Tradit Complement Altern Med | 10.4314/ajtcam.v10i5.20 | 2013 | |
| SRL172 (killed Mycobacterium vaccae) may augment the efficacy of trastuzumab in metastatic breast cancer patients. | Altundag K, Mohamed AS, Altundag O, Silay YS, Gunduz E, Demircan K. | Med Hypotheses | 10.1016/j.mehy.2004.07.016 | 2005 | ||
| Pilot study of the safety and effect of intranasal delipidated acid-treated Mycobacterium vaccae in adult asthma. | Shirtcliffe PM, Goldkorn A, Weatherall M, Tan PL, Beasley R. | Respirology | 10.1046/j.1440-1843.2003.00510.x | 2003 | ||
| Unveiling the Biosynthetic Pathway for Short Mycolic Acids in Nontuberculous Mycobacteria: Mycobacterium smegmatis MSMEG_4301 and Its Ortholog Mycobacterium abscessus MAB_1915 Are Essential for the Synthesis of alpha'-Mycolic Acids. | Di Capua CB, Belardinelli JM, Carignano HA, Buchieri MV, Suarez CA, Morbidoni HR. | Microbiol Spectr | 10.1128/spectrum.01288-22 | 2022 | ||
| Oral treatment with SRP299 (killed Mycobacterium vaccae) inhibits experimental periodontal disease in Wistar rats. | Breivik T, Rook GA. | J Clin Periodontol | 10.1034/j.1600-051x.2003.00405.x | 2003 | ||
| Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania. | Lahey T, Arbeit RD, Bakari M, Horsburgh CR, Matee M, Waddell R, Mtei L, Vuola JM, Pallangyo K, von Reyn CF. | Vaccine | 10.1016/j.vaccine.2010.09.041 | 2010 | ||
| Biodegradation of Tetrahydrofuran by the Newly Isolated Filamentous Fungus Pseudallescheria boydii ZM01. | Ren H, Li H, Wang H, Huang H, Lu Z. | Microorganisms | 10.3390/microorganisms8081190 | 2020 | ||
| A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanoma. | Nicholson S, Guile K, John J, Clarke IA, Diffley J, Donnellan P, Michael A, Szlosarek P, Dalgleish AG. | Melanoma Res | 10.1097/00008390-200308000-00008 | 2003 | ||
| Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages. | Arkwright PD, David TJ. | Br J Dermatol | 10.1111/j.1365-2133.2003.05557.x | 2003 | ||
| An open study to assess the efficacy clinically and immunologically of M. vaccae vaccine in patients with atopic dermatitis. | Davies MG, Symons C, Shaw S, Kaminski ER. | J Dermatolog Treat | 10.1080/09546630500515321 | 2006 | ||
| [Vaccination with Mycobacterium: can it cure allergies?]. | Louis R. | Rev Med Liege | 2003 | |||
| [Experimental study on prevention of diabetes complicated with tuberculosis by Mycobacterium vaccae]. | Chen H, Luo Y, Huang X, Guo S. | Zhonghua Jie He He Hu Xi Za Zhi | 2002 | |||
| The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma. | Camporota L, Corkhill A, Long H, Lordan J, Stanciu L, Tuckwell N, Cross A, Stanford JL, Rook GA, Holgate ST, Djukanovic R. | Eur Respir J | 10.1183/09031936.03.00042103 | 2003 | ||
| Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis. | Stanford J, Stanford C, Grange J. | Front Biosci | 10.2741/1292 | 2004 | ||
| Stress | Therapeutic treatment with heat-killed Mycobacterium vaccae (SRL172) in a mild and severe mouse model for allergic asthma. | Smit JJ, Van Loveren H, Hoekstra MO, Van der Kant PA, Folkerts G, Nijkamp FP. | Eur J Pharmacol | 10.1016/s0014-2999(03)01794-1 | 2003 | |
| [Constructing shuttle plasmid fusion expressing Ag85B-ESAT-6 on the surface of Mycobacterium]. | Shi CH, Fan XL, Shi JR, Xu ZK, Li Y, Bai YN, Xun Y. | Zhonghua Jie He He Hu Xi Za Zhi | 2004 | |||
| Pathogenicity | Synthesis and antileprosy activity of some dialkyldithiocarbamates. | Makarov V, Riabova OB, Yuschenko A, Urlyapova N, Daudova A, Zipfel PF, Mollmann U. | J Antimicrob Chemother | 10.1093/jac/dkl095 | 2006 | |
| Synthesis and Evaluation of Antimycobacterial and Antiplasmodial Activities of Hirsutellide A and Its Analogues. | Sahile HA, Martinez-Martinez MS, Dillenberger M, Becker K, Imming P. | ACS Omega | 10.1021/acsomega.0c01065 | 2020 | ||
| Mycobacterium vaccae administration during allergen sensitization or challenge suppresses asthmatic features. | Smit JJ, Van Loveren H, Hoekstra MO, Schijf MA, Folkerts G, Nijkamp FP. | Clin Exp Allergy | 10.1046/j.1365-2222.2003.01727.x | 2003 | ||
| Metabolism | Kinetics of 1,4-dioxane biodegradation by monooxygenase-expressing bacteria. | Mahendra S, Alvarez-Cohen L. | Environ Sci Technol | 10.1021/es060714v | 2006 | |
| Metabolism | Biosynthetic Plasticity Enables Production of Fluorinated Aurachins. | Sester A, Stuer-Patowsky K, Hiller W, Kloss F, Lutz S, Nett M. | Chembiochem | 10.1002/cbic.202000166 | 2020 | |
| Enzymology | Bxz1, a new generalized transducing phage for mycobacteria. | Lee S, Kriakov J, Vilcheze C, Dai Z, Hatfull GF, Jacobs WR. | FEMS Microbiol Lett | 10.1016/j.femsle.2004.10.032 | 2004 | |
| Levamisole as an Adjuvant to Short-Course Therapy in Newly Diagnosed Pulmonary Tuberculosis Patients. | Shamkuwar CA, Meshram SH, Mahakalkar SM. | Adv Biomed Res | 10.4103/2277-9175.203162 | 2017 | ||
| Determining the performance of a commercial air purification system for reducing airborne contamination using model micro-organisms: a new test methodology. | Griffiths WD, Bennett A, Speight S, Parks S. | J Hosp Infect | 10.1016/j.jhin.2005.03.004 | 2005 | ||
| Perspectives in asthma: molecular use of microbial products in asthma prevention and treatment. | Racila DM, Kline JN. | J Allergy Clin Immunol | 10.1016/j.jaci.2005.08.050 | 2005 | ||
| Treatment with SRL172 (heat-killed Mycobacterium vaccae) inhibits progression of established experimental periodontal disease in Wistar rats. | Brelvik T, Rook GA. | J Periodontal Res | 10.1034/j.1600-0765.2002.00352.x | 2002 | ||
| Impact of Mycobacterium vaccae immunization on lung histopathology in a murine model of chronic asthma. | Ozdemir C, Akkoc T, Bahceciler NN, Kucukercan D, Barlan IB, Basaran MM. | Clin Exp Allergy | 10.1046/j.1365-2222.2003.01595.x | 2003 | ||
| Metabolism | Trichloroethylene degradation by butane-oxidizing bacteria causes a spectrum of toxic effects. | Halsey KH, Sayavedra-Soto LA, Bottomley PJ, Arp DJ. | Appl Microbiol Biotechnol | 10.1007/s00253-005-1944-z | 2005 | |
| Genetics | Environmental Potential for Microbial 1,4-Dioxane Degradation Is Sparse despite Mobile Elements Playing a Role in Trait Distribution. | Goff KL, Hug LA. | Appl Environ Microbiol | 10.1128/aem.02091-21 | 2022 | |
| Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study. | Ouyang K, Hiremath J, Binjawadagi B, Shyu DL, Dhakal S, Arcos J, Schleappi R, Holman L, Roof M, Torrelles JB, Renukaradhya GJ. | Vet Res | 10.1186/s13567-016-0331-3 | 2016 | ||
| Immunotherapy with Mycobacterium vaccae and peripheral blood flow in long-treated leprosy patients, a randomised, placebo-controlled trial. | Abbot NC, Beck JS, Feval F, Weiss F, Mobayen MH, Ghazi-Saidi K, Dowlati Y, Velayati AA, Stanford JL. | Eur J Vasc Endovasc Surg | 10.1053/ejvs.2002.1716 | 2002 | ||
| Pathogenicity | Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cells. | Smith PL, Yogaratnam Y, Samad M, Kasow S, Dalgleish AG. | Clin Transl Oncol | 10.1007/s12094-020-02429-0 | 2021 | |
| Metabolism | Enhancement of beta-sitosterol transformation in Mycobacterium vaccae with increased cell wall permeability. | Korycka-Machala M, Rumijowska-Galewicz A, Lisowska K, Ziolkowskit A, Sedlacze L. | Acta Microbiol Pol | 2001 | ||
| Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. | Zuany-Amorim C, Manlius C, Trifilieff A, Brunet LR, Rook G, Bowen G, Pay G, Walker C. | J Immunol | 10.4049/jimmunol.169.3.1492 | 2002 | ||
| Metabolism | Robust NADH-regenerator: improved alpha-haloketone-resistant formate dehydrogenase. | Yamamoto H, Mitsuhashi K, Kimoto N, Kobayashi Y, Esaki N. | Appl Microbiol Biotechnol | 10.1007/s00253-004-1728-x | 2005 | |
| Pathogenicity | Acute cardio-respiratory effects in rats of PS4alpha, an antineoplastic peptidoglycan from Mycobacterium vaccae. | Villar VM, Morcillo EJ, Cortijo J, Reed A, Groves MJ. | J Pharm Pharmacol | 10.1211/0022357011776081 | 2001 | |
| Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. | Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, Bowen G, Rook G, Walker C. | Nat Med | 10.1038/nm0602-625 | 2002 | ||
| The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma. | Shirtcliffe PM, Easthope SE, Cheng S, Weatherall M, Tan PL, Le Gros G, Beasley R. | Am J Respir Crit Care Med | 10.1164/ajrccm.163.6.2003050 | 2001 | ||
| A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis. | Genovese MC, Chakravarty EF, Boyle DL, Tutuncu Z, Thorburn CM, Halilhodzic M, Kroll S, Baughman J, Stewart S, Kavanaugh A. | J Rheumatol | 2005 | |||
| iChip-Inspired Isolation, Bioactivities and Dereplication of Actinomycetota from Portuguese Beach Sediments. | Dos Santos JDN, Joao SA, Martin J, Vicente F, Reyes F, Lage OM. | Microorganisms | 10.3390/microorganisms10071471 | 2022 | ||
| Pathogenicity | Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus. | Sudadech P, Roytrakul S, Kaewprasert O, Sirichoat A, Chetchotisakd P, Kanthawong S, Faksri K. | PLoS One | 10.1371/journal.pone.0260003 | 2021 | |
| The ability of heat-killed Mycobacterium vaccae to stimulate a cytotoxic T-cell response to an unrelated protein is associated with a 65 kilodalton heat-shock protein. | Skinner MA, Prestidge R, Yuan S, Strabala TJ, Tan PL. | Immunology | 10.1046/j.1365-2567.2001.01174.x | 2001 | ||
| Formation of Nudicaulins In Vivo and In Vitro and the Biomimetic Synthesis and Bioactivity of O-Methylated Nudicaulin Derivatives. | Dudek B, Schnurrer F, Dahse HM, Paetz C, Warskulat AC, Weigel C, Voigt K, Schneider B. | Molecules | 10.3390/molecules23123357 | 2018 | ||
| How might contact with nature promote human health? Promising mechanisms and a possible central pathway. | Kuo M. | Front Psychol | 10.3389/fpsyg.2015.01093 | 2015 | ||
| A randomized pilot study of SRL172 (Mycobacterium vaccae) in patients with small cell lung cancer (SCLC) treated with chemotherapy. | Assersohn L, Souberbielle BE, O'Brien ME, Archer CD, Mendes R, Bass R, Bromelow KV, Palmer RD, Bouilloux E, Kennard DA, Smith IE. | Clin Oncol (R Coll Radiol) | 10.1053/clon.2001.0030 | 2002 | ||
| Metabolism | Aerobic biodegradation of N-nitrosodimethylamine (NDMA) by axenic bacterial strains. | Sharp JO, Wood TK, Alvarez-Cohen L. | Biotechnol Bioeng | 10.1002/bit.20405 | 2005 | |
| Mice with pulmonary tuberculosis treated with Mycobacterium vaccae develop strikingly enhanced recall gamma interferon responses to M. vaccae cell wall skeleton. | Rodriguez-Guell E, Agusti G, Corominas M, Cardona PJ, Luquin M, Julian E. | Clin Vaccine Immunol | 10.1128/cvi.00477-07 | 2008 | ||
| Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis. | Yang XY, Chen QF, Li YP, Wu SM. | PLoS One | 10.1371/journal.pone.0023826 | 2011 | ||
| Concomitant Mycobacterium tuberculosis infection promotes lung tumor growth through enhancing Treg development. | Zhou Y, Hu Z, Cao S, Yan B, Qian J, Zhong H. | Oncol Rep | 10.3892/or.2017.5733 | 2017 | ||
| Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial. | Mwinga A, Nunn A, Ngwira B, Chintu C, Warndorff D, Fine P, Darbyshire J, Zumla A, LUSKAR collaboration. | Lancet | 10.1016/s0140-6736(02)11141-x | 2002 | ||
| Impaired gamma interferon response to Mycobacterium vaccae antigens in patients with cavitary pulmonary tuberculosis. | Rodriguez-Guell E, Agusti G, Corominas M, Luquin M, Julian E. | Clin Vaccine Immunol | 10.1128/cvi.00131-08 | 2008 | ||
| Adaptations of Pseudoxylaria towards a comb-associated lifestyle in fungus-farming termite colonies. | Fricke J, Schalk F, Kreuzenbeck NB, Seibel E, Hoffmann J, Dittmann G, Conlon BH, Guo H, Wilhelm de Beer Z, Vassao DG, Gleixner G, Poulsen M, Beemelmanns C. | ISME J | 10.1038/s41396-023-01374-4 | 2023 | ||
| Improvement in psoriasis after intradermal administration of delipidated, deglycolipidated Mycobacterium vaccae (PVAC): results of an open-label trial. | Balagon MV, Tan PL, Prestidge R, Cellona RV, Abalos RM, Tan EV, Walsh GP, Watson JD, Walsh DS. | Clin Exp Dermatol | 10.1046/j.1365-2230.2001.00804.x | 2001 | ||
| Effect of BCG vaccination in asthmatic schoolchildren. | Vargas MH, Bernal-Alcantara DA, Vaca MA, Franco-Marina F, Lascurain R. | Pediatr Allergy Immunol | 10.1111/j.1399-3038.2004.00198.x | 2004 | ||
| Adjunctive immunotherapy of mycobacterial infections. | Tomioka H. | Curr Pharm Des | 10.2174/1381612043383232 | 2004 | ||
| Mucosal Immunoregulatory Properties of Tsukamurella inchonensis to Reverse Experimental Food Allergy. | Smaldini PL, Trejo FM, Rizzo GP, Comerci DJ, Kampinga J, Docena GH. | Front Immunol | 10.3389/fimmu.2021.641597 | 2021 | ||
| Metabolism | Polycations increase the permeability of Mycobacterium vaccae cell envelopes to hydrophobic compounds. | Korycka-Machala M, Ziolkowski A, Rumijowska-Galewicz A, Lisowska K, Sedlaczek L. | Microbiology (Reading) | 10.1099/00221287-147-10-2769 | 2001 | |
| [The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis]. | Luo Y, National Cooperation Group On Clinical Study Of Mycobacterium Vaccae Vaccine. | Zhonghua Jie He He Hu Xi Za Zhi | 2001 | |||
| Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. | Arkwright PD, David TJ. | J Allergy Clin Immunol | 10.1067/mai.2001.113081 | 2001 | ||
| Prevaccination with SRL172 (heat-killed Mycobacterium vaccae) inhibits experimental periodontal disease in Wistar rats. | Breivik T, Rook GA. | Clin Exp Immunol | 10.1046/j.1365-2249.2000.01231.x | 2000 | ||
| alpha-Pyrone Polyketides from Streptomyces ambofaciens BI0048, an Endophytic Actinobacterial Strain Isolated from the Red Alga Laurencia glandulifera. | Rab E, Kekos D, Roussis V, Ioannou E. | Mar Drugs | 10.3390/md15120389 | 2017 | ||
| Monophosphoryl Lipid A Tolerance Against Chronic Stress-Induced Depression-Like Behaviors in Mice. | Li F, Lu X, Ma Y, Gu Y, Ye T, Huang C. | Int J Neuropsychopharmacol | 10.1093/ijnp/pyab097 | 2022 | ||
| Metabolism | Enantioselective reduction of carbonyl compounds by whole-cell biotransformation, combining a formate dehydrogenase and a (R)-specific alcohol dehydrogenase. | Ernst M, Kaup B, Muller M, Bringer-Meyer S, Sahm H. | Appl Microbiol Biotechnol | 10.1007/s00253-004-1765-5 | 2005 | |
| Immunotherapy with mycobacteria. | Walker C, Sawicka E, Rook GA. | Curr Opin Allergy Clin Immunol | 10.1097/00130832-200312000-00010 | 2003 | ||
| Immunotherapy Using Autoclaved L. major Antigens and M. vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral Leishmaniasis. | Jamshidi Sh, Avizeh R, Mohebali M, Bokaie S. | Iran J Parasitol | 2011 | |||
| PVAC (Corixa/Genesis/Medicis). | Leopold CS, Maibach HI. | Curr Opin Investig Drugs | 2002 | |||
| Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis? | Stanford JL, Stanford CA, Grange JM, Lan NN, Etemadi A. | Respir Med | 10.1053/rmed.2001.1065 | 2001 | ||
| Current and emerging nonsteroidal anti-inflammatory therapies targeting specific mechanisms in asthma and allergy. | Bjermer L, Diamant Z. | Treat Respir Med | 10.2165/00151829-200403040-00004 | 2004 | ||
| Increased protection against bovine tuberculosis in the brushtail possum (Trichosurus vulpecula) when BCG is administered with killed Mycobacterium vaccae. | Skinner MA, Keen DL, Parlane NA, Yates GF, Buddle BM. | Tuberculosis (Edinb) | 10.1054/tube.2001.0318 | 2002 | ||
| Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97. | Mayo RE, Stanford JL. | Trans R Soc Trop Med Hyg | 10.1016/s0035-9203(00)90088-9 | 2000 | ||
| Isolation and identification of poly-alpha-(1-->4)-linked 3-O-methyl-D-mannopyranose from a hot-water extract of Mycobacterium vaccae. | Tian XX, Li A, Farrugia IV, Mo X, Crich D, Groves MJ. | Carbohydr Res | 10.1016/s0008-6215(99)00248-7 | 2000 | ||
| Metabolism | Stable carbon isotope fractionation during aerobic biodegradation of chlorinated ethenes. | Chu KH, Mahendra S, Song DL, Conrad ME, Alvarez-Cohen L. | Environ Sci Technol | 10.1021/es035238c | 2004 | |
| Genomic analysis of Mycobacterium brumae sustains its nonpathogenic and immunogenic phenotype. | Renau-Minguez C, Herrero-Abadia P, Ruiz-Rodriguez P, Sentandreu V, Torrents E, Chiner-Oms A, Torres-Puente M, Comas I, Julian E, Coscolla M. | Front Microbiol | 10.3389/fmicb.2022.982679 | 2022 | ||
| Pathogenicity | Targeting neuroinflammation as a preventive and therapeutic approach for perioperative neurocognitive disorders. | Cheng C, Wan H, Cong P, Huang X, Wu T, He M, Zhang Q, Xiong L, Tian L. | J Neuroinflammation | 10.1186/s12974-022-02656-y | 2022 | |
| Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration. | Johnson JL, Kamya RM, Okwera A, Loughlin AM, Nyole S, Hom DL, Wallis RS, Hirsch CS, Wolski K, Foulds J, Mugerwa RD, Ellner JJ. | J Infect Dis | 10.1086/315393 | 2000 | ||
| Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172). | Dlugovitzky D, Bottasso O, Dominino JC, Valentini E, Hartopp R, Singh M, Stanford C, Stanford J. | Respir Med | 10.1016/s0954-6111(99)90155-5 | 1999 | ||
| [Mycobacterium vaccae influences the kinetics of Th1/Th2 cells and expression of iNOS in a marine model of experimental tuberculosis]. | Zhang L, Ma W, Da J. | Zhonghua Jie He He Hu Xi Za Zhi | 2000 | |||
| Pathogenicity | Antimicrobial compounds from marine actinomycetes. | Wang C, Lu Y, Cao S. | Arch Pharm Res | 10.1007/s12272-020-01251-0 | 2020 | |
| [A clinical study on vaccine of Mycobacterium vaccae in treating pulmonary tuberculosis]. | Wang W, Jin G, Ye Y, Xia X, Wang A, Zhuang Y, Li G, Sun H, Wang Z, Lin M, Chen H, Li J, Dan Z, Zhang X. | Zhonghua Jie He He Hu Xi Za Zhi | 1999 | |||
| Improvement in psoriasis after intradermal administration of heat-killed Mycobacterium vaccae. | Balagon MV, Walsh DS, Tan PL, Cellona RV, Abalos RM, Tan EV, Fajardo TT, Watson JD, Walsh GP. | Int J Dermatol | 10.1046/j.1365-4362.2000.00862.x | 2000 | ||
| Pathogenicity | Harmonine, a defence compound from the harlequin ladybird, inhibits mycobacterial growth and demonstrates multi-stage antimalarial activity. | Rohrich CR, Ngwa CJ, Wiesner J, Schmidtberg H, Degenkolb T, Kollewe C, Fischer R, Pradel G, Vilcinskas A. | Biol Lett | 10.1098/rsbl.2011.0760 | 2012 | |
| One health pathogen surveillance demonstrated the dissemination of gut pathogens within the two coastal regions associated with intensive farming. | Wang Q, Zhang Y, Yang Q, Fu S, Qu B, Defoirdt T. | Gut Pathog | 10.1186/s13099-021-00442-4 | 2021 | ||
| [Experimental study on prevention of pneumoconiosis complicating with tuberculosis by Mycobacterium vaccae]. | Yang Z, Duan L, Guan Y. | Zhonghua Jie He He Hu Xi Za Zhi | 1997 | |||
| The Slc11a1 (Nramp1) gene controls efficacy of mycobacterial treatment of allergic asthma. | Smit JJ, Van Loveren H, Hoekstra MO, Karimi K, Folkerts G, Nijkamp FP. | J Immunol | 10.4049/jimmunol.171.2.754 | 2003 | ||
| Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis. | Waddell RD, Chintu C, Lein AD, Zumla A, Karagas MR, Baboo KS, Habbema JD, Tosteson AN, Morin P, Tvaroha S, Arbeit RD, Mwinga A, von Reyn CF. | Clin Infect Dis | 10.1086/313880 | 2000 | ||
| Metabolism | Metabolic engineering of Escherichia coli: construction of an efficient biocatalyst for D-mannitol formation in a whole-cell biotransformation. | Kaup B, Bringer-Meyer S, Sahm H. | Appl Microbiol Biotechnol | 10.1007/s00253-003-1470-9 | 2004 | |
| The Progress of Therapeutic Vaccination with Regard to Tuberculosis. | Cardona PJ. | Front Microbiol | 10.3389/fmicb.2016.01536 | 2016 | ||
| Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction. | Ji C, Lin W, Moraski GC, Thanassi JA, Pucci MJ, Franzblau SG, Mollmann U, Miller MJ. | Bioorg Med Chem | 10.1016/j.bmc.2012.04.026 | 2012 | ||
| In Vivo Selection for Formate Dehydrogenases with High Efficiency and Specificity toward NADP. | Calzadiaz-Ramirez L, Calvo-Tusell C, Stoffel GMM, Lindner SN, Osuna S, Erb TJ, Garcia-Borras M, Bar-Even A, Acevedo-Rocha CG. | ACS Catal | 10.1021/acscatal.0c01487 | 2020 | ||
| Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial. | Vuola JM, Ristola MA, Cole B, Jarviluoma A, Tvaroha S, Ronkko T, Rautio O, Arbeit RD, von Reyn CF. | AIDS | 10.1097/00002030-200311070-00010 | 2003 | ||
| [Immunotherapeutic effect of Mycobacterium vaccae on multi-drug resistant pulmonary tuberculosis]. | Luo Y, Lu S, Guo S. | Zhonghua Jie He He Hu Xi Za Zhi | 2000 | |||
| Randomised trial of intradermal Mycobacterium vaccae or intradermal hepatitis B immunisation in children with HIV infection. | Johnson D, Waddell RD, Pelton SI, Jaeger AS, Modlin JF, Yogev R, Morin P, Arbeit RD, von Reyn CF. | Vaccine | 10.1016/s0264-410x(99)00055-9 | 1999 | ||
| Designing tuberculosis vaccine efficacy trials - lessons from recent studies. | Ginsberg AM. | Expert Rev Vaccines | 10.1080/14760584.2019.1593143 | 2019 | ||
| Mycobacterium vaccae (SRL172): a potential immunological adjuvant evaluated in rat prostate cancer. | Hrouda D, Souberbielle BE, Kayaga J, Corbishley CM, Kirby RS, Dalgleish AG. | Br J Urol | 10.1046/j.1464-410x.1998.00881.x | 1998 | ||
| Contribution of Home Gardens to Sustainable Development: Perspectives from A Supported Opinion Essay. | Santos M, Moreira H, Cabral JA, Gabriel R, Teixeira A, Bastos R, Aires A. | Int J Environ Res Public Health | 10.3390/ijerph192013715 | 2022 | ||
| Metabolism | Effect of interactions between amino acid residues 43 and 61 on thermal stability of bacterial formate dehydrogenases. | Fedorchuk VV, Galkin AG, Yasny IE, Kulakova LB, Rojkova AM, Filippova AA, Tishkov VI. | Biochemistry (Mosc) | 10.1023/a:1020915324159 | 2002 | |
| Enzymology | Isolation and biological activities of an antineoplastic protein-polysaccharide complex (PS4A) obtained from Mycobacterium vaccae. | Tian XX, Li A, Zhou W, Farrugia IV, Groves MJ. | Anticancer Res | 1999 | ||
| Potential improvements of the cognition of piglets through a synbiotic supplementation from 1 to 28 days via the gut microbiota. | Parois SP, Eicher SD, Lindemann SR, Marchant JN. | Sci Rep | 10.1038/s41598-021-03565-5 | 2021 | ||
| [Eradication of leprosy and public health. Vaccination and multidrug therapy]. | Janaszek W. | Przegl Epidemiol | 2002 | |||
| Management of pulmonary nontuberculous mycobacterial disease. | Horan KL, Skerrett SJ. | F1000 Med Rep | 10.3410/m1-99 | 2009 | ||
| Cellular immune responses to mycobacteria in healthy and human immunodeficiency virus-positive subjects in the United States after a five-dose schedule of Mycobacterium vaccae vaccine. | von Reyn CF, Marsh BJ, Waddell R, Lein AD, Tvaroha S, Morin P, Modlin JF. | Clin Infect Dis | 10.1086/515024 | 1998 | ||
| Metabolism | Intracellular localization of the mycobacterial stressosome complex. | Ramesh M, Nitharwal RG, Behra PRK, Fredrik Pettersson BM, Dasgupta S, Kirsebom LA. | Sci Rep | 10.1038/s41598-021-89069-8 | 2021 | |
| Enzymology | MftG is crucial for ethanol metabolism of mycobacteria by linking mycofactocin oxidation to respiration. | Graca AP, Nikitushkin V, Ellerhorst M, Vilhena C, Klassert TE, Starick A, Siemers M, Al-Jammal WK, Vilotijevic I, Slevogt H, Papenfort K, Lackner G. | Elife | 10.7554/elife.97559 | 2025 | |
| Enzymology | Azteca ants maintain unique microbiomes across functionally distinct nest chambers. | Lucas JM, Madden AA, Penick CA, Epps MJ, Marting PR, Stevens JL, Fergus DJ, Dunn RR, Meineke EK. | Proc Biol Sci | 10.1098/rspb.2019.1026 | 2019 | |
| A Cassette Containing Thiostrepton, Gentamicin Resistance Genes, and dif sequences Is Effective in Construction of Recombinant Mycobacteria. | Mugweru J, Makafe G, Cao Y, Zhang Y, Wang B, Huang S, Njire M, Chhotaray C, Tan Y, Li X, Liu J, Tan S, Deng J, Zhang T. | Front Microbiol | 10.3389/fmicb.2017.00468 | 2017 | ||
| Immunotherapy with Mycobacterium vaccae in the treatment of psoriasis. | Lehrer A, Bressanelli A, Wachsmann V, Bottasso O, Bay ML, Singh M, Stanford C, Stanford J. | FEMS Immunol Med Microbiol | 10.1111/j.1574-695x.1998.tb01151.x | 1998 | ||
| Social Defeat Modulates T Helper Cell Percentages in Stress Susceptible and Resilient Mice. | Ambree O, Ruland C, Zwanzger P, Klotz L, Baune BT, Arolt V, Scheu S, Alferink J. | Int J Mol Sci | 10.3390/ijms20143512 | 2019 | ||
| Vaccination against leprosy at Ben San Leprosy Centre, Ho Chi Minh City, Vietnam. | Truoc LV, Ly HM, Thuy NK, Trach DD, Stanford CA, Stanford JL. | Vaccine | 10.1016/s0264-410x(01)00052-4 | 2001 | ||
| Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis. | Crocquet-Valdes PA, Diaz-Montero CM, Feng HM, Li H, Barrett AD, Walker DH. | Vaccine | 10.1016/s0264-410x(01)00377-2 | 2001 | ||
| Immunotherapy of advanced prostate cancer: a phase I/II trial using Mycobacterium vaccae (SRL172). | Hrouda D, Baban B, Dunsmuir WD, Kirby RS, Dalgleish AG. | Br J Urol | 10.1046/j.1464-410x.1998.00803.x | 1998 | ||
| Metabolism | Biodegradation of groundwater pollutants by a combined culture of Mycobacterium vaccae and a Rhodococcus sp. | Fairlee JR, Burback BL, Perry JJ. | Can J Microbiol | 10.1139/m97-122 | 1997 | |
| Genetic fusion of P450 BM3 and formate dehydrogenase towards self-sufficient biocatalysts with enhanced activity. | Kokorin A, Parshin PD, Bakkes PJ, Pometun AA, Tishkov VI, Urlacher VB. | Sci Rep | 10.1038/s41598-021-00957-5 | 2021 | ||
| Enzymology | Formulation and biological activity of antineoplastic proteoglycans derived from Mycobacterium vaccae in chitosan nanoparticles. | Tian XX, Groves MJ. | J Pharm Pharmacol | 10.1211/0022357991772268 | 1999 | |
| Perioperative neurocognitive dysfunction: thinking from the gut? | Xu X, Hu Y, Yan E, Zhan G, Liu C, Yang C. | Aging (Albany NY) | 10.18632/aging.103738 | 2020 | ||
| Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. | Wang CC, Rook GA. | Immunology | 10.1046/j.1365-2567.1998.00432.x | 1998 | ||
| Identification of a CG/LH binding site in two strains of Mycobacterium vaccae. | Carrell DT, Woods ME, Griffin J, Odell WD. | Endocr Res | 10.1080/07435809709031842 | 1997 | ||
| Mucosal immunity in the brushtail possum (Trichosurus vulpecula): detection of antibody in serum and at female reproductive sites after intranasal immunization. | Doolin EE, Wedlock DN, Buddle BM, Skinner MA. | Immunol Cell Biol | 10.1046/j.1440-1711.2002.01096.x | 2002 | ||
| Metabolism | Discovery of an Inducible Toluene Monooxygenase That Cooxidizes 1,4-Dioxane and 1,1-Dichloroethylene in Propanotrophic Azoarcus sp. Strain DD4. | Deng D, Pham DN, Li F, Li M. | Appl Environ Microbiol | 10.1128/aem.01163-20 | 2020 | |
| Pathogenicity | Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs. | Hiremath J, Kang KI, Xia M, Elaish M, Binjawadagi B, Ouyang K, Dhakal S, Arcos J, Torrelles JB, Jiang X, Lee CW, Renukaradhya GJ. | PLoS One | 10.1371/journal.pone.0151922 | 2016 | |
| Enzymology | Expression, purification and characterization of Mycobacterium tuberculosis RpfE protein. | Xue Y, Bai Y, Gao X, Jiang H, Wang L, Gao H, Xu Z. | J Biomed Res | 10.1016/s1674-8301(12)60003-7 | 2012 | |
| [Effects of vaccae on airway inflammation and Th1/Th2 cytokines in sensitized mice]. | Xie Q, Bian R, Wu K, Zheng X. | Zhonghua Jie He He Hu Xi Za Zhi | 2002 | |||
| Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. | Hopfenspirger MT, Agrawal DK. | J Immunol | 10.4049/jimmunol.168.5.2516 | 2002 | ||
| Allogeneic whole-cell vaccine: a phase I/II study in men with hormone-refractory prostate cancer. | Eaton JD, Perry MJ, Nicholson S, Guckian M, Russell N, Whelan M, Kirby RS. | BJU Int | 10.1046/j.1464-410x.2002.02572.x | 2002 | ||
| In silico predicted therapy against chronic Staphylococcus aureus infection leads to bacterial clearance in vivo. | Papaxenopoulou LA, Zhao G, Khailaie S, Katsoulis-Dimitriou K, Schmitz I, Medina E, Hatzikirou H, Meyer-Hermann M. | iScience | 10.1016/j.isci.2022.105522 | 2022 | ||
| Immunization of HIV-infected adults with a three-dose series of inactivated Mycobacterium vaccae. | Marsh BJ, Fordham von Reyn C, Arbeit RD, Morin P. | Am J Med Sci | 10.1097/00000441-199706000-00011 | 1997 | ||
| Il-4 influences apoptosis of mycobacterium-reactive lymphocytes in the presence of TNF-alpha. | Seah GT, Rook GA. | J Immunol | 10.4049/jimmunol.167.3.1230 | 2001 | ||
| Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis. | Hernandez-Pando R, Aguilar D, Orozco H, Cortez Y, Brunet LR, Rook GA. | Clin Vaccine Immunol | 10.1128/cvi.00286-08 | 2008 | ||
| [Effects of vaccae on airway contraction and inflammation in asthmatic guinea pigs]. | Zhao XY, Xie QM, Chen JQ, Bian RL. | Zhonghua Jie He He Hu Xi Za Zhi | 2003 | |||
| Metabolism | Biodegradation of trichloroethylene by Mycobacterium vaccae. | Vanderberg LA, Burback BL, Perry JJ. | Can J Microbiol | 10.1139/m95-041 | 1995 | |
| Cutaneous and pulmonary infections caused by Mycobacterium vaccae. | Hachem R, Raad I, Rolston KV, Whimbey E, Katz R, Tarrand J, Libshitz H. | Clin Infect Dis | 10.1093/clinids/23.1.173 | 1996 | ||
| Perfusing chemotherapy by percutaneous lung puncture in the treatment of extensive drug resistant pulmonary tuberculosis. | Yang SH, Zhan P, Sun M, Zhang YP, Ma NL. | J Thorac Dis | 10.3978/j.issn.2072-1439.2012.06.09 | 2012 | ||
| Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 2. Chronic or relapsed disease. | Corlan E, Marica C, Macavei C, Stanford JL, Stanford CA. | Respir Med | 10.1016/s0954-6111(97)90133-5 | 1997 | ||
| Immunization of healthy adult subjects in the United States with inactivated Mycobacterium vaccae administered in a three-dose series. | von Reyn CF, Arbeit RD, Yeaman G, Waddell RD, Marsh BJ, Morin P, Modlin JF, Remold HG. | Clin Infect Dis | 10.1093/clinids/24.5.843 | 1997 | ||
| Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine. | von Reyn CF, Mtei L, Arbeit RD, Waddell R, Cole B, Mackenzie T, Matee M, Bakari M, Tvaroha S, Adams LV, Horsburgh CR, Pallangyo K, DarDar Study Group. | AIDS | 10.1097/qad.0b013e3283350f1b | 2010 | ||
| Mycobacterial antigens attenuate late phase response, airway hyperresponsiveness, and bronchoalveolar lavage eosinophilia in a mouse model of bronchial asthma. | Hopfenspirger MT, Parr SK, Hopp RJ, Townley RG, Agrawal DK. | Int Immunopharmacol | 10.1016/s1567-5769(01)00084-4 | 2001 | ||
| Transcriptome | Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis-induced injury. | Wang N, Liang Y, Ma Q, Mi J, Xue Y, Yang Y, Wang L, Wu X. | Immun Inflamm Dis | 10.1002/iid3.854 | 2023 | |
| Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model. | Janssen R, Kruisselbrink A, Hoogteijling L, Lamb JR, Young DB, Thole JE. | Immunology | 10.1046/j.1365-2567.2001.01207.x | 2001 | ||
| Metabolism | Cloning of formate dehydrogenase gene from a methanol-utilizing bacterium Mycobacterium vaccae N10. | Galkin A, Kulakova L, Tishkov V, Esaki N, Soda K. | Appl Microbiol Biotechnol | 10.1007/bf00169947 | 1995 | |
| Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary disease. | Corlan E, Marica C, Macavei C, Stanford JL, Stanford CA. | Respir Med | 10.1016/s0954-6111(97)90132-3 | 1997 | ||
| Metabolism | Catabolism of 2,4,6-trinitrotoluene by Mycobacterium vaccae. | Vanderberg LA, Perry JJ, Unkefer PJ. | Appl Microbiol Biotechnol | 10.1007/bf02431931 | 1995 | |
| Ag85A/ESAT-6 chimeric DNA vaccine induces an adverse response in tuberculosis-infected mice. | Liang Y, Bai X, Zhang J, Song J, Yang Y, Yu Q, Li N, Wu X. | Mol Med Rep | 10.3892/mmr.2016.5364 | 2016 | ||
| Avian immune responses to Mycobacterium avium: the wildfowl example. | Cromie RL, Ash NJ, Brown MJ, Stanford JL. | Dev Comp Immunol | 10.1016/s0145-305x(99)00071-3 | 2000 | ||
| Tuberculosis in Swiss captive Asian elephants: microevolution of Mycobacterium tuberculosis characterized by multilocus variable-number tandem-repeat analysis and whole-genome sequencing. | Ghielmetti G, Coscolla M, Ruetten M, Friedel U, Loiseau C, Feldmann J, Steinmetz HW, Stucki D, Gagneux S. | Sci Rep | 10.1038/s41598-017-15278-9 | 2017 | ||
| Metabolism | Effects of repeated voluntary or forced exercise on brainstem serotonergic systems in rats. | Arnold MR, Greenwood BN, McArthur JA, Clark PJ, Fleshner M, Lowry CA. | Behav Brain Res | 10.1016/j.bbr.2019.112237 | 2020 | |
| Pathogenicity | Ethanol in Combination with Oxidative Stress Significantly Impacts Mycobacterial Physiology. | Patel Y, Rai D, Das K, Dhandayuthapani S, Mehra S. | J Bacteriol | 10.1128/jb.00222-20 | 2020 | |
| Enzymology | Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Monawarah, Saudi Arabia. | Elhassan MM, Hemeg HA, Elmekki MA, Turkistani KA, Abdul-Aziz AA. | Infect Disord Drug Targets | 10.2174/1871526517666161116104242 | 2017 | |
| Mycobacterium w - a promising immunotherapeutic intervention for diseases. | Stefan K, Gordon R, Rolig A, Honkala A, Tailor D, Davis LE, Modi RI, Joshipura M, Khamar B, Malhotra SV. | Front Immunol | 10.3389/fimmu.2024.1450118 | 2024 | ||
| Tuberculosis II: the failure of the BCG vaccine. | Maes RF. | Med Hypotheses | 10.1054/mehy.1997.0706 | 1999 | ||
| Allogeneic whole-tumour cell vaccination in the rat model of prostate cancer. | Hrouda D, Todryk SM, Perry MJ, Souberbielle BE, Kayaga J, Kirby RS, Dalgleish AG. | BJU Int | 10.1046/j.1464-410x.2000.00887.x | 2000 | ||
| Interactions between hormone-mediated and vaccine-mediated immunotherapy for pulmonary tuberculosis in BALB/c mice. | Hernandez-Pando R, Pavon L, Orozco EH, Rangel J, Rook GA. | Immunology | 10.1046/j.1365-2567.2000.00054.x | 2000 | ||
| Studies of vaccination of persons in close contact with leprosy patients in Argentina. | Bottasso O, Merlin V, Cannon L, Cannon H, Ingledew N, Keni M, Hartopp R, Stanford C, Stanford J. | Vaccine | 10.1016/s0264-410x(98)80115-1 | 1998 | ||
| Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers. | Noguera-Ortega E, Guallar-Garrido S, Julian E. | Cancers (Basel) | 10.3390/cancers12071802 | 2020 | ||
| A review of the BCG vaccine and other approaches toward tuberculosis eradication. | Cho T, Khatchadourian C, Nguyen H, Dara Y, Jung S, Venketaraman V. | Hum Vaccin Immunother | 10.1080/21645515.2021.1885280 | 2021 | ||
| Metabolism | Dehalogenation by Mycobacterium vaccae JOB-5: role of the propane monooxygenase. | Vanderberg LA, Perry JJ. | Can J Microbiol | 10.1139/m94-029 | 1994 | |
| Syntheses and biological evaluation of new cephalosporin-oxazolidinone conjugates. | Yan S, Miller MJ, Wencewicz TA, Moollmann U. | Medchemcomm | 10.1039/c0md00015a | 2010 | ||
| Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity. | Sorensen B, Susrud A, Dalgleish AG. | QRB Discov | 10.1017/qrd.2020.8 | 2020 | ||
| Metabolism | Biodegradation of Methyl tert-Butyl Ether by Co-Metabolism with a Pseudomonas sp. Strain. | Li S, Wang S, Yan W. | Int J Environ Res Public Health | 10.3390/ijerph13090883 | 2016 | |
| Metabolism | Role of a bacillus Calmette-Guérin fibronectin attachment protein in BCG-induced antitumor activity. | Zhao W, Schorey JS, Bong-Mastek M, Ritchey J, Brown EJ, Ratliff TL. | Int J Cancer | 10.1002/(sici)1097-0215(20000401)86:1<83::aid-ijc13>3.0.co;2-r | 2000 | |
| Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. | Buddle BM, Keen D, Thomson A, Jowett G, McCarthy AR, Heslop J, De Lisle GW, Stanford JL, Aldwell FE. | Res Vet Sci | 10.1016/0034-5288(95)90023-3 | 1995 | ||
| The site-specific recombination locus of mycobacteriophage Ms6 determines DNA integration at the tRNA(Ala) gene of Mycobacterium spp. | Freitas-Vieira A, Anes E, Moniz-Pereira J. | Microbiology (Reading) | 10.1099/00221287-144-12-3397 | 1998 | ||
| Enzymology | Characterisation of a new host-vector system for fast-growing mycobacteria. | Golanska E, Brzostek A, Kiatpapan P, Dziadek J. | Acta Microbiol Pol | 1998 | ||
| Metabolism | Formate dehydrogenase in a reversed micelle system: regulation of catalytic activity and oligomeric composition of the enzyme. | Klyachko NL, Vakula SV, Gladyshev VN, Tishkov VI, Levashov AV. | Biochemistry (Mosc) | 1997 | ||
| Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial. | Matee M, Lahey T, Vuola JM, Mtei L, Cole BF, Bakari M, Arbeit RD, Horsburgh CR, Pallangyo K, von Reyn CF. | J Infect Dis | 10.1086/509896 | 2007 | ||
| Metabolism | Postselective (directed) mutagenesis of fast-growing strain of Mycobacterium vaccae as a method of creating mutants showing changed phenotypic properties. | Sajduda A, Dziadek J, Golanska E, Rumijowska A, Jaworski A. | Acta Microbiol Pol | 1994 | ||
| Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa. | Onyebujoh PC, Abdulmumini T, Robinson S, Rook GA, Stanford JL. | Respir Med | 10.1016/0954-6111(95)90248-1 | 1995 | ||
| Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country. | Kuo CH, Lo CY, Chung FT, Lee KY, Lin SM, Wang CH, Heh CC, Chen HC, Kuo HP. | PLoS One | 10.1371/journal.pone.0033226 | 2012 | ||
| Pharmacotherapy for multidrug resistant tuberculosis. | Chhabra N, Aseri ML, Dixit R, Gaur S. | J Pharmacol Pharmacother | 10.4103/0976-500x.95502 | 2012 | ||
| Metabolism | Immunological and endocrinological characteristics of tuberculosis that provide opportunities for immunotherapeutic intervention. | Rook GA, Hernandez-Pando R. | Novartis Found Symp | 10.1002/0470846526.ch6 | 1998 | |
| A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis. | Dalbeth N, Yeoman S, Dockerty JL, Highton J, Robinson E, Tan PL, Herman D, McQueen FM. | Ann Rheum Dis | 10.1136/ard.2003.007104 | 2004 | ||
| Metabolism | Recalcitrance of 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) to cometabolic degradation by pure cultures of aerobic and anaerobic bacteria. | Megharaj M, Jovcic A, Boul HL, Thiele JH. | Arch Environ Contam Toxicol | 10.1007/s002449900235 | 1997 | |
| Modification of immune response by low dose ionizing radiation: role of apoptosis. | Shankar B, Premachandran S, Bharambe SD, Sundaresan P, Sainis KB. | Immunol Lett | 10.1016/s0165-2478(99)00074-7 | 1999 | ||
| Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention. | Zhuang L, Yang L, Li L, Ye Z, Gong W. | MedComm (2020) | 10.1002/mco2.419 | 2024 | ||
| Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis. | Lahey T, Laddy D, Hill K, Schaeffer J, Hogg A, Keeble J, Dagg B, Ho MM, Arbeit RD, von Reyn CF. | PLoS One | 10.1371/journal.pone.0168521 | 2016 | ||
| Metabolism | Microbial degradation of 2 alpha, 3 alpha-dihydroxy-5 alpha-cholestan-6-one by Mycobacterium vaccae. | Vorbrodt HM, Adam G, Porzel A, Horhold C, Danhardt S, Bohme KH. | Steroids | 10.1016/0039-128x(91)90021-m | 1991 | |
| Metabolism | Selection and characterization of new microorganisms for the manufacture of 9-OH-AD from sterols. | Seidel L, Horhold C. | J Basic Microbiol | 10.1002/jobm.3620320115 | 1992 | |
| Synthesis, Bacteriostatic and Anticancer Activity of Novel Phenanthridines Structurally Similar to Benzo[c]phenanthridine Alkaloids. | Lasak P, Motyka K, Krystof V, Styskala J. | Molecules | 10.3390/molecules23092155 | 2018 | ||
| Antimycobacterial activity of a Brevibacillus laterosporusstrain isolated from a moroccan soil. | Hassi M, Guendouzi SE, Haggoud A, David S, Ibnsouda S, Houari A, Iraqui M. | Braz J Microbiol | 10.1590/s1517-838220120004000036 | 2012 | ||
| The efficacy and safety of immunotherapy in patients with advanced NSCLC: a systematic review and meta-analysis. | Zhou L, Wang XL, Deng QL, Du YQ, Zhao NQ. | Sci Rep | 10.1038/srep32020 | 2016 | ||
| A Systematic Scoping Literature Review of Publications Supporting Treatment Guidelines for Pediatric Atopic Dermatitis in Contrast to Clinical Practice Patterns. | Siegfried EC, Jaworski JC, Mina-Osorio P. | Dermatol Ther (Heidelb) | 10.1007/s13555-018-0243-4 | 2018 | ||
| The effect of natural adjuvants on pathological changes in sensitized Guinea pig lungs. | Neamati A, Boskabady MH, Tabatabaei A, Mohaghegh Hazrati S. | Iran Red Crescent Med J | 10.5812/ircmj.14267 | 2014 | ||
| Enzymology | Alternative NAD(+)-dependent formate dehydrogenases in the facultative methylotroph Mycobacterium vaccae 10. | Karzanov VV, Correa CM, Bogatsky YG, Netrusov AI. | FEMS Microbiol Lett | 10.1016/0378-1097(91)90478-s | 1991 | |
| Tuberculosis and cancer: parallels in host responses and therapeutic approaches? | Grange JM, Stanford JL, Rook GA. | Lancet | 10.1016/s0140-6736(95)92542-2 | 1995 | ||
| Characterization of a haemolysin from Mycobacterium tuberculosis with homology to a virulence factor of Serpulina hyodysenteriae. | Wren BW, Stabler RA, Das SS, Butcher PD, Mangan JA, Clarke JD, Casali N, Parish T, Stoker NG. | Microbiology (Reading) | 10.1099/00221287-144-5-1205 | 1998 | ||
| Development of a SOD ELISA to determine the immunological relatedness among mycobacteria. | Shivannavar CT, Katoch VM, Sharma VD, Patil MA, Katoch K, Bharadwaj VP, Agrawal BM. | Int J Lepr Other Mycobact Dis | 1996 | |||
| Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis. | Stanford JL, Rook GA, Bahr GM, Dowlati Y, Ganapati R, Ghazi Saidi K, Lucas S, Ramu G, Torres P, Minh Ly H. | Vaccine | 10.1016/0264-410x(90)90002-4 | 1990 | ||
| Understanding the Intrinsic and Extrinsic Motivations Associated with Community Gardening to Improve Environmental Public Health Prevention and Intervention. | Ramirez-Andreotta MD, Tapper A, Clough D, Carrera JS, Sandhaus S. | Int J Environ Res Public Health | 10.3390/ijerph16030494 | 2019 | ||
| Characterization of Milkisin, a Novel Lipopeptide With Antimicrobial Properties Produced By Pseudomonas sp. UCMA 17988 Isolated From Bovine Raw Milk. | Schlusselhuber M, Godard J, Sebban M, Bernay B, Garon D, Seguin V, Oulyadi H, Desmasures N. | Front Microbiol | 10.3389/fmicb.2018.01030 | 2018 | ||
| Epidemiology and treatment of psoriasis: a Brazilian perspective. | Duarte GV, Porto-Silva L, de Oliveira MFP. | Psoriasis (Auckl) | 10.2147/ptt.s51725 | 2015 | ||
| Tuberculosis in Africa--any news? | van der Werf TS. | Trop Geogr Med | 1994 | |||
| [A drug delivery system and biological response modifiers for the treatment of mycobacterial infection]. | Koga H, Miyazaki Y, Kohno S, Hara K. | Kekkaku | 1994 | |||
| Polyantigenic interferon-gamma responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization. | Lahey T, Mitchell BK, Arbeit RD, Sheth S, Matee M, Horsburgh CR, MacKenzie T, Mtei L, Bakari M, Vuola JM, Pallangyo K, von Reyn CF. | PLoS One | 10.1371/journal.pone.0022074 | 2011 | ||
| Propane-Induced biodegradation of vapor phase trichoroethylene. | Wilcox DW, Autenrieth RL, Bonner JS. | Biotechnol Bioeng | 10.1002/bit.260460406 | 1995 | ||
| Pathogenicity | Transformation of mycobacterial species using hygromycin resistance as selectable marker. | Garbe TR, Barathi J, Barnini S, Zhang Y, Abou-Zeid C, Tang D, Mukherjee R, Young DB. | Microbiology (Reading) | 10.1099/13500872-140-1-133 | 1994 | |
| Metabolism | [Microbial degradation of beta-sitosterol: production of delta 4-androstene-3,17-dione]. | Wang JY, Yin ZH, Zhou WS. | Yao Xue Xue Bao | 1992 | ||
| HIV: treating tuberculosis. | Payne B, Bellamy R. | BMJ Clin Evid | 2009 | |||
| Efficient biocatalytic stereoselective reduction of methyl acetoacetate catalyzed by whole cells of engineered E. coli. | Cui YH, Wei P, Peng F, Zong MH, Lou WY. | RSC Adv | 10.1039/c8ra00883c | 2018 | ||
| A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma. | O'Brien ME, Saini A, Smith IE, Webb A, Gregory K, Mendes R, Ryan C, Priest K, Bromelow KV, Palmer RD, Tuckwell N, Kennard DA, Souberbielle BE. | Br J Cancer | 10.1054/bjoc.2000.1401 | 2000 | ||
| Antigen-presenting cells (APC) of mice with chronic graft-versus-host disease (GVHD) cause excessive activation-induced death of T helper cells. | Haridas V, Kamat RS. | Clin Exp Immunol | 10.1046/j.1365-2249.1997.4391461.x | 1997 | ||
| Metabolism | Staphylococcus succinus 14BME20 Prevents Allergic Airway Inflammation by Induction of Regulatory T Cells via Interleukin-10. | Song J, Lim HX, Lee A, Kim S, Lee JH, Kim TS. | Front Immunol | 10.3389/fimmu.2019.01269 | 2019 | |
| Pathogenicity | Innate immune stimulation by monophosphoryl lipid A prevents chronic social defeat stress-induced anxiety-like behaviors in mice. | Li F, Xiang H, Gu Y, Ye T, Lu X, Huang C. | J Neuroinflammation | 10.1186/s12974-021-02377-8 | 2022 | |
| Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial. | Ndiaye BP, Thienemann F, Ota M, Landry BS, Camara M, Dieye S, Dieye TN, Esmail H, Goliath R, Huygen K, January V, Ndiaye I, Oni T, Raine M, Romano M, Satti I, Sutton S, Thiam A, Wilkinson KA, Mboup S, Wilkinson RJ, McShane H, MVA85A 030 trial investigators. | Lancet Respir Med | 10.1016/s2213-2600(15)00037-5 | 2015 | ||
| Effect of vaccines in a murine model of dormant tuberculosis. | Dhillon J, Mitchison DA. | Tuber Lung Dis | 10.1016/0962-8479(94)90105-8 | 1994 | ||
| Pathogenicity | A study on viability of mycobacteria after treating them with complement system. | Parkash O, Ramanathan VD, Mukherjee A, Sengupta U. | Acta Leprol | 1992 | ||
| Metabolism | A longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy. | Rook GA, Onyebujoh P, Wilkins E, Ly HM, al Attiyah R, Bahr G, Corrah T, Hernandez H, Stanford JL. | Immunology | 1994 | ||
| Adrenal changes in murine pulmonary tuberculosis; a clue to pathogenesis? | Hernandez-Pando R, Orozco H, Honour J, Silva P, Leyva R, Rook GA. | FEMS Immunol Med Microbiol | 10.1111/j.1574-695x.1995.tb00176.x | 1995 | ||
| Improved immunotherapy for pulmonary tuberculosis with Mycobacterium vaccae. | Bahr GM, Shaaban MA, Gabriel M, al-Shimali B, Siddiqui Z, Chugh TD, Denath FM, Shahin A, Behbehani K, Chedid L. | Tubercle | 10.1016/0041-3879(90)90038-a | 1990 | ||
| Genetics | A genomic analysis of Mycobacterium immunogenum strain CD11_6 and its potential role in the activation of T cells against Mycobacterium tuberculosis. | Kaur G, Chander AM, Kaur G, Maurya SK, Nadeem S, Kochhar R, Bhadada SK, Agrewala JN, Mayilraj S. | BMC Microbiol | 10.1186/s12866-019-1421-y | 2019 | |
| Pathogenicity | Less immune activation following social stress in rural vs. urban participants raised with regular or no animal contact, respectively. | Bobel TS, Hackl SB, Langgartner D, Jarczok MN, Rohleder N, Rook GA, Lowry CA, Gundel H, Waller C, Reber SO. | Proc Natl Acad Sci U S A | 10.1073/pnas.1719866115 | 2018 | |
| Immunotherapy with Mycobacterium vaccae as an adjunct to chemotherapy in the treatment of pulmonary tuberculosis. | Stanford JL, Bahr GM, Rook GA, Shaaban MA, Chugh TD, Gabriel M, al-Shimali B, Siddiqui Z, Ghardani F, Shahin A. | Tubercle | 10.1016/0041-3879(90)90002-p | 1990 | ||
| An investigation of patients with pulmonary tuberculosis in Kuwait in preparation for studies of immunotherapy with Mycobacterium vaccae. | Bahr GM, Stanford JL, Chugh TD, Shaaban MA, Gabriel M, al-Shimali B, Siddiqui Z, Ghardani F, Rook GA, Shahin A. | Tubercle | 10.1016/0041-3879(90)90001-o | 1990 | ||
| Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study. | Bodemer C, Guillet G, Cambazard F, Boralevi F, Ballarini S, Milliet C, Bertuccio P, La Vecchia C, Bach JF, de Prost Y. | PLoS One | 10.1371/journal.pone.0161555 | 2017 | ||
| Antimicrobial potentials of natural products against multidrug resistance pathogens: a comprehensive review. | Elmaidomy AH, Shady NH, Abdeljawad KM, Elzamkan MB, Helmy HH, Tarshan EA, Adly AN, Hussien YH, Sayed NG, Zayed A, Abdelmohsen UR. | RSC Adv | 10.1039/d2ra04884a | 2022 | ||
| The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis. | Schoenmakers A, Mieras L, Budiawan T, van Brakel WH. | Res Rep Trop Med | 10.2147/rrtm.s190300 | 2020 | ||
| Neonatal, atopic and infectious disease outcomes among children born to mothers with latent tuberculosis infection. | Dosanjh A, Eridon J, Koziol J. | J Asthma Allergy | 10.2147/jaa.s42458 | 2013 | ||
| Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection. | Tian M, Zhou Z, Tan S, Fan X, Li L, Ullah N. | Front Immunol | 10.3389/fimmu.2018.00310 | 2018 | ||
| Metabolism | Murine CD8+ T suppressors against mycobacterial 65-kDa antigen compete for IL-2 and show lack of major histocompatibility complex-imposed restriction specificity in antigen recognition. | Khetan S, Sainis KB, Rath S, Kamat R. | Eur J Immunol | 10.1002/eji.1830231010 | 1993 | |
| TNF alpha-mediated tissue damage in mouse footpads primed with mycobacterial preparations. | al Attiyah R, Moreno C, Rook GA. | Res Immunol | 10.1016/0923-2494(92)80041-i | 1992 | ||
| The effect of oral Mycobacterium vaccae on subsequent responses of mice to BCG sensitization. | Brown CA, Brown IN, Swinburne S. | Tubercle | 10.1016/0041-3879(85)90062-5 | 1985 | ||
| Comparative Genomics and Proteomic Analysis of Four Non-tuberculous Mycobacterium Species and Mycobacterium tuberculosis Complex: Occurrence of Shared Immunogenic Proteins. | Gcebe N, Michel A, Gey van Pittius NC, Rutten V. | Front Microbiol | 10.3389/fmicb.2016.00795 | 2016 | ||
| Metabolism | Iron uptake processes in Mycobacterium vaccae R877R, a mycobacterium lacking mycobactin. | Messenger AJ, Hall RM, Ratledge C. | J Gen Microbiol | 10.1099/00221287-132-3-845 | 1986 | |
| Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma. | Mendes R, O'Brien ME, Mitra A, Norton A, Gregory RK, Padhani AR, Bromelow KV, Winkley AR, Ashley S, Smith IE, Souberbielle BE. | Br J Cancer | 10.1038/sj.bjc.6600063 | 2002 | ||
| Metabolism | Microbial reduction of 1-(4-fluorophenyl)-4-[4-(5-fluoro-2-pyrimidinyl)-1- piperazinyl]butan-1-one. | Patel RN, Banerjee A, Liu M, Hanson R, Ko R, Howell J, Szarka LJ. | Biotechnol Appl Biochem | 10.1111/j.1470-8744.1993.tb00235.x | 1993 | |
| Improving on BCG. | Stanford JL. | APMIS | 10.1111/j.1699-0463.1991.tb05127.x | 1991 | ||
| A Retrospective Study of 17 Cases of Mycobacteriosis in Domestic Ferrets (Mustela Putorius furo) between 2005 and 2013. | Mentre V, Bulliot C. | J Exot Pet Med | 10.1053/j.jepm.2015.06.019 | 2015 | ||
| HPLC-DAD and UHPLC/QTOF-MS Analysis of Polyphenols in Extracts of the African Species Combretum padoides, C. zeyheri and C. psidioides Related to Their Antimycobacterial Activity. | Fyhrquist P, Salih EYA, Helenius S, Laakso I, Julkunen-Tiitto R. | Antibiotics (Basel) | 10.3390/antibiotics9080459 | 2020 | ||
| Surface spreading motility shown by a group of phylogenetically related, rapidly growing pigmented mycobacteria suggests that motility is a common property of mycobacterial species but is restricted to smooth colonies. | Agusti G, Astola O, Rodriguez-Guell E, Julian E, Luquin M. | J Bacteriol | 10.1128/jb.00572-08 | 2008 | ||
| Immunization with a heat-killed preparation of the environmental bacterium Mycobacterium vaccae promotes stress resilience in mice. | Reber SO, Siebler PH, Donner NC, Morton JT, Smith DG, Kopelman JM, Lowe KR, Wheeler KJ, Fox JH, Hassell JE, Greenwood BN, Jansch C, Lechner A, Schmidt D, Uschold-Schmidt N, Fuchsl AM, Langgartner D, Walker FR, Hale MW, Lopez Perez G, Van Treuren W, Gonzalez A, Halweg-Edwards AL, Fleshner M, Raison CL, Rook GA, Peddada SD, Knight R, Lowry CA. | Proc Natl Acad Sci U S A | 10.1073/pnas.1600324113 | 2016 | ||
| Pathogenesis of route-related variation in T-suppressor response on immunization with mycobacteria. | Shroff KE, Sengupta SR, Kamat RS. | Int J Lepr Other Mycobact Dis | 1990 | |||
| The current status, challenges, and future developments of new tuberculosis vaccines. | Gong W, Liang Y, Wu X. | Hum Vaccin Immunother | 10.1080/21645515.2018.1458806 | 2018 | ||
| Identification of a novel B-cell epitope of restricted specificity on the hsp 65-kDa protein of Mycobacterium tuberculosis. | Rambukkana A, Yong S, Das PK. | FEMS Microbiol Immunol | 10.1111/j.1574-6968.1991.tb04161.x | 1991 | ||
| Electron microscopic observations of cell division in Mycobacterium vaccae V1. | Takade A, Takeya K, Taniguchi H, Mizuguchi Y. | J Gen Microbiol | 10.1099/00221287-129-7-2315 | 1983 | ||
| Metabolism | Synthesis of short-chain diols and unsaturated alcohols from secondary alcohol substrates by the Rieske nonheme mononuclear iron oxygenase MdpJ. | Schafer F, Schuster J, Wurz B, Hartig C, Harms H, Muller RH, Rohwerder T. | Appl Environ Microbiol | 10.1128/aem.01434-12 | 2012 | |
| Route-related variation in immunogenicity of mycobacteria. | Shroff KE, Sengupta SR, Kamat RS. | Int J Lepr Other Mycobact Dis | 1990 | |||
| Determination and evolutionary significance of nucleotide sequences near to the 3'-end of 16S ribosomal RNA of mycobacteria. | Estrada-G IC, Colston MJ, Cox RA. | FEMS Microbiol Lett | 10.1016/0378-1097(89)90212-7 | 1989 | ||
| Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients. | Wowk PF, Franco LH, Fonseca DMD, Paula MO, Vianna EDSO, Wendling AP, Augusto VM, Eloi-Santos SM, Teixeira-Carvalho A, Silva FDC, Vinhas SA, Martins-Filho OA, Palaci M, Silva CL, Bonato VLD. | Hum Vaccin Immunother | 10.1080/21645515.2016.1264547 | 2017 | ||
| Role of immunotherapy in the treatment of tuberculosis. | Murthy KJ, Vijaya Lakshmi V, Singh S. | Indian J Clin Biochem | 10.1007/bf02873067 | 1997 | ||
| Role of antigen-presenting cells in variation in immunogenicity of mycobacteria. | Shroff KE, Sainis KB, Sengupta SR, Kamat RS. | Clin Exp Immunol | 10.1111/j.1365-2249.1990.tb05192.x | 1990 | ||
| Neonatal bacillus Calmette-Guérin vaccination inhibits de novo allergic inflammatory response in mice via alteration of CD4+CD25+ T-regulatory cells. | Li Q, Shen HH. | Acta Pharmacol Sin | 10.1038/aps.2008.3 | 2009 | ||
| Major histocompatibility complex restriction of T-cell suppression of immune response to mycobacteria. | Shroff KE, Sainis KB, Sengupta SR, Kamat RS. | Int J Lepr Other Mycobact Dis | 1991 | |||
| Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901. | von Reyn CF, Lahey T, Arbeit RD, Landry B, Kailani L, Adams LV, Haynes BC, Mackenzie T, Wieland-Alter W, Connor RI, Tvaroha S, Hokey DA, Ginsberg AM, Waddell R. | PLoS One | 10.1371/journal.pone.0175215 | 2017 | ||
| A pilot study of three potential vaccines for leprosy in Bombay. | Ganapati R, Revankar CR, Lockwood DN, Wilson RC, Price JE, Ashton P, Ashton LA, Holmes RM, Bennett C, Stanford JL. | Int J Lepr Other Mycobact Dis | 1989 | |||
| Unveiling unusual features of formation of septal partition and constriction in mycobacteria--an ultrastructural study. | Vijay S, Anand D, Ajitkumar P. | J Bacteriol | 10.1128/jb.06184-11 | 2012 | ||
| Arylmethylamino steroids as antiparasitic agents. | Krieg R, Jortzik E, Goetz AA, Blandin S, Wittlin S, Elhabiri M, Rahbari M, Nuryyeva S, Voigt K, Dahse HM, Brakhage A, Beckmann S, Quack T, Grevelding CG, Pinkerton AB, Schonecker B, Burrows J, Davioud-Charvet E, Rahlfs S, Becker K. | Nat Commun | 10.1038/ncomms14478 | 2017 | ||
| Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants. | Franco AR, Peri F. | Cells | 10.3390/cells10010078 | 2021 | ||
| Metabolism | Induction of methyl tertiary butyl ether (MTBE)-oxidizing activity in Mycobacterium vaccae JOB5 by MTBE. | Johnson EL, Smith CA, O'Reilly KT, Hyman MR. | Appl Environ Microbiol | 10.1128/aem.70.2.1023-1030.2004 | 2004 | |
| Vaccination and skin test studies on the children of leprosy patients. | Stanford JL, Stanford CA, Ghazi Saidi K, Dowlati Y, Weiss SF, Farshchi Y, Madlener F, Rees RJ. | Int J Lepr Other Mycobact Dis | 1989 | |||
| Metabolism | Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior. | Lowry CA, Hollis JH, de Vries A, Pan B, Brunet LR, Hunt JR, Paton JF, van Kampen E, Knight DM, Evans AK, Rook GA, Lightman SL. | Neuroscience | 10.1016/j.neuroscience.2007.01.067 | 2007 | |
| Enzymology | Identification of polyketide inhibitors targeting 3-dehydroquinate dehydratase in the shikimate pathway of Enterococcus faecalis. | Cheung VW, Xue B, Hernandez-Valladares M, Go MK, Tung A, Aguda AH, Robinson RC, Yew WS. | PLoS One | 10.1371/journal.pone.0103598 | 2014 | |
| Pathogenicity | Clinical and Basic Studies on Therapeutic Efficacy of Herbal Medicines against Mycobacterial Infections. | Tomioka H, Tatano Y, Shimizu T, Sano C. | Medicines (Basel) | 10.3390/medicines6020067 | 2019 | |
| Intradermal injection of Hsp60 induces cytokine responses in canine atopic and healthy skin. | Jassies-van der Lee A, Rutten V, van Kooten P, van der Zee R, Willemse T. | Cell Stress Chaperones | 10.1007/s12192-008-0029-1 | 2008 | ||
| Pathogenicity | Splenic glucocorticoid resistance following psychosocial stress requires physical injury. | Foertsch S, Fuchsl AM, Faller SD, Holzer H, Langgartner D, Messmann J, Strauss G, Reber SO. | Sci Rep | 10.1038/s41598-017-15897-2 | 2017 | |
| Enzymology | Patterns and distribution of aminoglycoside-acetylating enzymes in rapidly growing mycobacteria. | Udou T, Mizuguchi Y, Wallace RJ. | Am Rev Respir Dis | 10.1164/ajrccm/136.2.338 | 1987 | |
| Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy. | Sheikh JA, Khuller GK, Verma I. | J Immune Based Ther Vaccines | 10.1186/1476-8518-9-4 | 2011 | ||
| Enzymology | Construction of genomic libraries of mycobacterial origin: identification of recombinants encoding mycobacterial-specific proteins. | Khandekar PS, Munshi A, Sinha S, Sharma G, Kapoor A, Gaur A, Talwar GP. | Int J Lepr Other Mycobact Dis | 1986 | ||
| Pathogenicity | Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. | Russell SL, Gold MJ, Hartmann M, Willing BP, Thorson L, Wlodarska M, Gill N, Blanchet MR, Mohn WW, McNagny KM, Finlay BB. | EMBO Rep | 10.1038/embor.2012.32 | 2012 | |
| Mycobacteria isolated from deer in New Zealand from 1970-1983. | de Lisle GW, Havill PF. | N Z Vet J | 10.1080/00480169.1985.35198 | 1985 | ||
| Preparation and biological evaluation of novel leucomycin analogs derived from nitroso Diels-Alder reactions. | Yang B, Zollner T, Gebhardt P, Mollmann U, Miller MJ. | Org Biomol Chem | 10.1039/b922450e | 2010 | ||
| Antigenic evaluation of mycobacterium vaccae in relation to Mycobacterium leprae. | Navalkar RG, Chaparas SD, Lakshiminarayana CK, Kanchana MV. | Int J Lepr Other Mycobact Dis | 1980 | |||
| Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis. | Ghazi Saidi K, Stanford JL, Stanford CA, Dowlati Y, Farshchi Y, Rook GA, Rees RJ. | Int J Lepr Other Mycobact Dis | 1989 | |||
| Pathogenicity | Vaccines versus immunotherapy: overview of approaches in deciding between options. | Dalgleish AG. | Hum Vaccin Immunother | 10.4161/21645515.2014.980707 | 2014 | |
| Metabolism | Mycobactin and the competition for iron between Mycobacterium neoaurum and M. vaccae. | Hall RM, Ratledge C. | J Gen Microbiol | 10.1099/00221287-132-3-839 | 1986 | |
| Metabolism | Toward homosuccinate fermentation: metabolic engineering of Corynebacterium glutamicum for anaerobic production of succinate from glucose and formate. | Litsanov B, Brocker M, Bott M. | Appl Environ Microbiol | 10.1128/aem.07790-11 | 2012 | |
| Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis. | Gong W, Liang Y, Wu X. | Biomed Res Int | 10.1155/2020/4263079 | 2020 | ||
| Metabolism | Antibiotic-producing symbionts dynamically transition between plant pathogenicity and insect-defensive mutualism. | Florez LV, Scherlach K, Gaube P, Ross C, Sitte E, Hermes C, Rodrigues A, Hertweck C, Kaltenpoth M. | Nat Commun | 10.1038/ncomms15172 | 2017 | |
| Intranasally administered antigen 85B gene vaccine in non-replicating human Parainfluenza type 2 virus vector ameliorates mouse atopic dermatitis. | Kitagawa H, Kawano M, Yamanaka K, Kakeda M, Tsuda K, Inada H, Yoneda M, Sakaguchi T, Nigi A, Nishimura K, Komada H, Tsurudome M, Yasutomi Y, Nosaka T, Mizutani H. | PLoS One | 10.1371/journal.pone.0066614 | 2013 | ||
| Metabolism | Addition of formate dehydrogenase increases the production of renewable alkane from an engineered metabolic pathway. | Jaroensuk J, Intasian P, Kiattisewee C, Munkajohnpon P, Chunthaboon P, Buttranon S, Trisrivirat D, Wongnate T, Maenpuen S, Tinikul R, Chaiyen P. | J Biol Chem | 10.1074/jbc.ra119.008246 | 2019 | |
| A Locus at 5q33.3 Confers Resistance to Tuberculosis in Highly Susceptible Individuals. | Sobota RS, Stein CM, Kodaman N, Scheinfeldt LB, Maro I, Wieland-Alter W, Igo RP, Magohe A, Malone LL, Chervenak K, Hall NB, Modongo C, Zetola N, Matee M, Joloba M, Froment A, Nyambo TB, Moore JH, Scott WK, Lahey T, Boom WH, von Reyn CF, Tishkoff SA, Sirugo G, Williams SM. | Am J Hum Genet | 10.1016/j.ajhg.2016.01.015 | 2016 | ||
| Metabolism | Biodegradation and biotransformation of groundwater pollutant mixtures by Mycobacterium vaccae. | Burback BL, Perry JJ. | Appl Environ Microbiol | 10.1128/aem.59.4.1025-1029.1993 | 1993 | |
| Th2 responses in OVA-sensitized BALB/c mice are down-modulated by Mycobacterium bovis BCG treatment. | Gouveia AC, Brugiolo AS, Alves CC, Silva FM, Mesquita FP, Gameiro J, Ferreira AP. | J Clin Immunol | 10.1007/s10875-012-9746-4 | 2013 | ||
| Metabolism | Fate of the C1 product of propane dissimilation in Mycobacterium vaccae. | Coleman JP, Perry JJ. | J Bacteriol | 10.1128/jb.160.3.1163-1164.1984 | 1984 | |
| Enzymology | Assessment of Formate Dehydrogenase Stress Stability In vivo using Inactivation by Hydrogen Peroxide. | Savin SS, Tishkov VI. | Acta Naturae | 10.32607/20758251-2010-2-1-97-101 | 2010 | |
| Metabolism | Characterization of the initial reactions during the cometabolic oxidation of methyl tert-butyl ether by propane-grown Mycobacterium vaccae JOB5. | Smith CA, O'Reilly KT, Hyman MR. | Appl Environ Microbiol | 10.1128/aem.69.2.796-804.2003 | 2003 | |
| Pathogenicity | Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa. | Berditsch M, Jager T, Strempel N, Schwartz T, Overhage J, Ulrich AS. | Antimicrob Agents Chemother | 10.1128/aac.00682-15 | 2015 | |
| Induction of T cell responses and recruitment of an inflammatory dendritic cell subset following tumor immunotherapy with Mycobacterium smegmatis. | Rich FJ, Kuhn S, Hyde EJ, Harper JL, Ronchese F, Kirman JR. | Cancer Immunol Immunother | 10.1007/s00262-012-1291-8 | 2012 | ||
| Immunization via the anal mucosa and adjacent skin to protect against respiratory virus infections and allergic rhinitis: a hypothesis. | Lloyd Spencer J. | Med Hypotheses | 10.1016/j.mehy.2009.09.046 | 2010 | ||
| Oral Administration of Heat-Killed Mycobacterium manresensis Delays Progression toward Active Tuberculosis in C3HeB/FeJ Mice. | Cardona P, Marzo-Escartin E, Tapia G, Diaz J, Garcia V, Varela I, Vilaplana C, Cardona PJ. | Front Microbiol | 10.3389/fmicb.2015.01482 | 2015 | ||
| Pathogenicity | Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress. | Bharwani A, Mian MF, Surette MG, Bienenstock J, Forsythe P. | BMC Med | 10.1186/s12916-016-0771-7 | 2017 | |
| Modeling Child-Nature Interaction in a Nature Preschool: A Proof of Concept. | Kahn PH, Weiss T, Harrington K. | Front Psychol | 10.3389/fpsyg.2018.00835 | 2018 | ||
| Two potential improvements to BCG and their effect on skin test reactivity in the Lebanon. | Bahr GM, Stanford JL, Rook GA, Rees RJ, Abdelnoor AM, Frayha GJ. | Tubercle | 10.1016/s0041-3879(86)80027-7 | 1986 | ||
| Phylogeny | Insights on the emergence of Mycobacterium tuberculosis from the analysis of Mycobacterium kansasii. | Wang J, McIntosh F, Radomski N, Dewar K, Simeone R, Enninga J, Brosch R, Rocha EP, Veyrier FJ, Behr MA. | Genome Biol Evol | 10.1093/gbe/evv035 | 2015 | |
| Pathogenicity | In vitro inhibition of murine B-cell tumor growth by MDP, MDP(D-D) and Vaccin is mediated by macrophages. | Moras ML, Phillips NC, Bahr GM, Chedid L. | Int J Immunopharmacol | 10.1016/0192-0561(85)90071-2 | 1985 | |
| Metabolism | Chaulmoogric acid: assimilation into the complex lipids of mycobacteria. | Cabot MC, Goucher CR. | Lipids | 10.1007/bf02535690 | 1981 | |
| Enzymology | Advantages of using matrix-assisted laser desorption ionization-time of flight mass spectrometry as a rapid diagnostic tool for identification of yeasts and mycobacteria in the clinical microbiological laboratory. | Chen JH, Yam WC, Ngan AH, Fung AM, Woo WL, Yan MK, Choi GK, Ho PL, Cheng VC, Yuen KY. | J Clin Microbiol | 10.1128/jcm.01437-13 | 2013 | |
| Enzymology | Use of a recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasi for the Immunotherapy of canine visceral Leishmaniasis. | Ferreira JH, Silva Ldos S, Longo-Maugeri IM, Katz S, Barbieri CL. | PLoS Negl Trop Dis | 10.1371/journal.pntd.0002729 | 2014 | |
| Genetics | A chromosome 5q31.1 locus associates with tuberculin skin test reactivity in HIV-positive individuals from tuberculosis hyper-endemic regions in east Africa. | Sobota RS, Stein CM, Kodaman N, Maro I, Wieland-Alter W, Igo RP, Magohe A, Malone LL, Chervenak K, Hall NB, Matee M, Mayanja-Kizza H, Joloba M, Moore JH, Scott WK, Lahey T, Boom WH, von Reyn CF, Williams SM, Sirugo G. | PLoS Genet | 10.1371/journal.pgen.1006710 | 2017 | |
| Chloroform Cometabolism by Butane-Grown CF8, Pseudomonas butanovora, and Mycobacterium vaccae JOB5 and Methane-Grown Methylosinus trichosporium OB3b. | Hamamura N, Page C, Long T, Semprini L, Arp DJ. | Appl Environ Microbiol | 10.1128/aem.63.9.3607-3613.1997 | 1997 | ||
| Inhibition of the proliferative response of peripheral blood lymphocytes to mycobacterial or fungal antigens by co-stimulation with antigens from various mycobacterial species. | Bahr GM, Rook GA, Stanford JL. | Immunology | 1981 | |||
| Enzymology | BactQuant: an enhanced broad-coverage bacterial quantitative real-time PCR assay. | Liu CM, Aziz M, Kachur S, Hsueh PR, Huang YT, Keim P, Price LB. | BMC Microbiol | 10.1186/1471-2180-12-56 | 2012 | |
| The effect of delayed addition of antigen and 'E' rosetting on the proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal individuals or from patients with tuberculosis or leprosy. | Bahr GM, Rook GA, Stanford JL, Lydyard PM, Bryceson AD. | Immunology | 1981 | |||
| Exosomes carrying mycobacterial antigens can protect mice against Mycobacterium tuberculosis infection. | Cheng Y, Schorey JS. | Eur J Immunol | 10.1002/eji.201343727 | 2013 | ||
| Metabolism | Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders. | Hale MW, Shekhar A, Lowry CA. | Cell Mol Neurobiol | 10.1007/s10571-012-9827-1 | 2012 | |
| The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: Part II: scientific advances that may provide solutions. | Ellner JJ. | Clin Transl Sci | 10.1111/j.1752-8062.2008.00086.x | 2009 | ||
| British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). | Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, Leitch A, Loebinger MR, Milburn HJ, Nightingale M, Ormerod P, Shingadia D, Smith D, Whitehead N, Wilson R, Floto RA. | BMJ Open Respir Res | 10.1136/bmjresp-2017-000242 | 2017 | ||
| Metabolism | The origin of fatty acids in the hydrocarbon-utilizing microorganism Mycobacterium vaccae. | King DH, Perry JJ. | Can J Microbiol | 10.1139/m75-012 | 1975 | |
| Metabolism | Exploitation of Hetero- and Phototrophic Metabolic Modules for Redox-Intensive Whole-Cell Biocatalysis. | Theodosiou E, Tullinghoff A, Toepel J, Buhler B. | Front Bioeng Biotechnol | 10.3389/fbioe.2022.855715 | 2022 | |
| Vaccination of mice against Mycobacterium leprae infection. | Singh NB, Lowe AC, Rees RJ, Colston MJ. | Infect Immun | 10.1128/iai.57.2.653-655.1989 | 1989 | ||
| T cell reactivity against mycolyl transferase antigen 85 of M. tuberculosis in HIV-TB coinfected subjects and in AIDS patients suffering from tuberculosis and nontuberculous mycobacterial infections. | Launois P, Drowart A, Bourreau E, Couppie P, Farber CM, Van Vooren JP, Huygen K. | Clin Dev Immunol | 10.1155/2011/640309 | 2011 | ||
| T regulatory cells: an overview and intervention techniques to modulate allergy outcome. | Nandakumar S, Miller CW, Kumaraguru U. | Clin Mol Allergy | 10.1186/1476-7961-7-5 | 2009 | ||
| Phylogeny | Numerical analysis of relationships among rapidly growing, scotochromogenic mycobacteria. | Tsukamura M, Mizuno S. | J Gen Microbiol | 10.1099/00221287-98-2-511 | 1977 | |
| Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders. | Breit S, Kupferberg A, Rogler G, Hasler G. | Front Psychiatry | 10.3389/fpsyt.2018.00044 | 2018 | ||
| Advances in the Diagnosis, Treatment and Control of HIV Associated Tuberculosis. | Kirenga BJ, Chanda DM, Muwonge CM, Yimer G, Adatu FE, Onyebujoh PC. | Afr J Infect Dis | 10.4314/ajid.v6i2.2 | 2012 | ||
| Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future? | Bowe WP, Logan AC. | Gut Pathog | 10.1186/1757-4749-3-1 | 2011 | ||
| Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. | Abou-Zeid C, Gares MP, Inwald J, Janssen R, Zhang Y, Young DB, Hetzel C, Lamb JR, Baldwin SL, Orme IM, Yeremeev V, Nikonenko BV, Apt AS. | Infect Immun | 10.1128/iai.65.5.1856-1862.1997 | 1997 | ||
| Characterization of temperate phage Che12 and construction of a new tool for diagnosis of tuberculosis. | Kumar V, Loganathan P, Sivaramakrishnan G, Kriakov J, Dusthakeer A, Subramanyam B, Chan J, Jacobs WR, Paranji Rama N. | Tuberculosis (Edinb) | 10.1016/j.tube.2008.02.007 | 2008 | ||
| Ag85B DNA vaccine suppresses airway inflammation in a murine model of asthma. | Wu J, Xu J, Cai C, Gao X, Li L, Zhong N. | Respir Res | 10.1186/1465-9921-10-51 | 2009 | ||
| Pathogenicity | Highly parallelized droplet cultivation and prioritization of antibiotic producers from natural microbial communities. | Mahler L, Niehs SP, Martin K, Weber T, Scherlach K, Hertweck C, Roth M, Rosenbaum MA. | Elife | 10.7554/elife.64774 | 2021 | |
| Effects of cytokine milieu secreted by BCG-treated dendritic cells on allergen-specific Th immune response. | Koh YI, Choi IS, Lee JJ. | J Korean Med Sci | 10.3346/jkms.2004.19.5.640 | 2004 | ||
| Metabolism | Metabolism of n-butane and 2-butanone by Mycobacterium vaccae. | Phillips WE, Perry JJ. | J Bacteriol | 10.1128/jb.120.2.987-989.1974 | 1974 | |
| Harnessing regulatory T cells to suppress asthma: from potential to therapy. | Thorburn AN, Hansbro PM. | Am J Respir Cell Mol Biol | 10.1165/rcmb.2009-0342tr | 2010 | ||
| Interferon gamma responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis. | Lahey T, Sheth S, Matee M, Arbeit R, Horsburgh CR, Mtei L, Mackenzie T, Bakari M, Vuola JM, Pallangyo K, von Reyn CF. | J Infect Dis | 10.1086/656332 | 2010 | ||
| Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III - convergence toward clinical trials. | Bested AC, Logan AC, Selhub EM. | Gut Pathog | 10.1186/1757-4749-5-4 | 2013 | ||
| Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice. | Ahmad F, Mani J, Kumar P, Haridas S, Upadhyay P, Bhaskar S. | PLoS One | 10.1371/journal.pone.0025424 | 2011 | ||
| An epitope delivery system for use with recombinant mycobacteria. | Hetzel C, Janssen R, Ely SJ, Kristensen NM, Bunting K, Cooper JB, Lamb JR, Young DB, Thole JE. | Infect Immun | 10.1128/iai.66.8.3643-3648.1998 | 1998 | ||
| TSLP directly impairs pulmonary Treg function: association with aberrant tolerogenic immunity in asthmatic airway. | Nguyen KD, Vanichsarn C, Nadeau KC. | Allergy Asthma Clin Immunol | 10.1186/1710-1492-6-4 | 2010 | ||
| Salmonella enterica serovar Typhimurium infection-induced CD11b+ Gr1+ cells ameliorate allergic airway inflammation. | Ganesh V, Baru AM, Hesse C, Friedrich C, Glage S, Gohmert M, Janke C, Sparwasser T. | Infect Immun | 10.1128/iai.01378-13 | 2014 | ||
| Metabolism | Metabolism of 2-methylpropene (isobutylene) by the aerobic bacterium Mycobacterium sp. strain ELW1. | Kottegoda S, Waligora E, Hyman M. | Appl Environ Microbiol | 10.1128/aem.03103-14 | 2015 | |
| Stress | Protection against tuberculosis in Eurasian wild boar vaccinated with heat-inactivated Mycobacterium bovis. | Garrido JM, Sevilla IA, Beltran-Beck B, Minguijon E, Ballesteros C, Galindo RC, Boadella M, Lyashchenko KP, Romero B, Geijo MV, Ruiz-Fons F, Aranaz A, Juste RA, Vicente J, de la Fuente J, Gortazar C. | PLoS One | 10.1371/journal.pone.0024905 | 2011 | |
| Targeting persisters for tuberculosis control. | Zhang Y, Yew WW, Barer MR. | Antimicrob Agents Chemother | 10.1128/aac.06288-11 | 2012 | ||
| Pulmonary bovine-type tuberculosis in rabbits: bacillary virulence, inhaled dose effects, tuberculin sensitivity, and Mycobacterium vaccae immunotherapy. | Converse PJ, Dannenberg AM, Shigenaga T, McMurray DN, Phalen SW, Stanford JL, Rook GA, Koru-Sengul T, Abbey H, Estep JE, Pitt ML. | Clin Diagn Lab Immunol | 10.1128/cdli.5.6.871-881.1998 | 1998 | ||
| Metabolism | Diversity in butane monooxygenases among butane-grown bacteria. | Hamamura N, Storfa RT, Semprini L, Arp DJ. | Appl Environ Microbiol | 10.1128/aem.65.10.4586-4593.1999 | 1999 | |
| Clinical efficacy and laboratory improvement of bacillus calmette-guerin vaccination on adult atopic asthma: a cohort study. | Datau EA, Mewengkang H, Matheos JC, Purnawan I, Wibisono M, Wongdjaja K, Wibowo C, Surachmanto E, Salim FP. | World Allergy Organ J | 10.1097/wox.0b013e31816c8b85 | 2008 | ||
| Enzymology | Survey of microbial oxygenases: trichloroethylene degradation by propane-oxidizing bacteria. | Wackett LP, Brusseau GA, Householder SR, Hanson RS. | Appl Environ Microbiol | 10.1128/aem.55.11.2960-2964.1989 | 1989 | |
| Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion. | da Fonseca DM, Silva CL, Wowk PF, Paula MO, Ramos SG, Horn C, Marchal G, Bonato VL. | Infect Immun | 10.1128/iai.00580-09 | 2009 | ||
| Metabolism | Involvement of a novel enzyme, MdpA, in methyl tert-butyl ether degradation in Methylibium petroleiphilum PM1. | Schmidt R, Battaglia V, Scow K, Kane S, Hristova KR. | Appl Environ Microbiol | 10.1128/aem.01192-08 | 2008 | |
| Metabolism | Incorporation of chlorinated alkanes into fatty acids of hydrocarbon-utilizing mycobacteria. | Murphy GL, Perry JJ. | J Bacteriol | 10.1128/jb.156.3.1158-1164.1983 | 1983 | |
| Metabolism | Purification of a mycobacterial adhesin for fibronectin. | Ratliff TL, McCarthy R, Telle WB, Brown EJ. | Infect Immun | 10.1128/iai.61.5.1889-1894.1993 | 1993 | |
| Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro. | Post FA, Manca C, Neyrolles O, Ryffel B, Young DB, Kaplan G. | Infect Immun | 10.1128/iai.69.3.1433-1439.2001 | 2001 | ||
| Metabolism | Lsr2 peptides of Mycobacterium leprae show hierarchical responses in lymphoproliferative assays, with selective recognition by patients with anergic lepromatous leprosy. | Chaduvula M, Murtaza A, Misra N, Narayan NP, Ramesh V, Prasad HK, Rani R, Chinnadurai RK, Nath I. | Infect Immun | 10.1128/iai.05384-11 | 2012 | |
| Metabolism | Product repression of alkane monooxygenase expression in Pseudomonas butanovora. | Doughty DM, Sayavedra-Soto LA, Arp DJ, Bottomley PJ. | J Bacteriol | 10.1128/jb.188.7.2586-2592.2006 | 2006 | |
| Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas. | Kasprowicz VO, Churchyard G, Lawn SD, Squire SB, Lalvani A. | J Infect Dis | 10.1093/infdis/jir449 | 2011 | ||
| Pathogenicity | Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife? | Converse PJ, Nuermberger EL, Almeida DV, Grosset JH. | Future Microbiol | 10.2217/fmb.11.101 | 2011 | |
| Stimulation of allergen-loaded macrophages by TLR9-ligand potentiates IL-10-mediated suppression of allergic airway inflammation in mice. | Vissers JL, van Esch BC, Jeurink PV, Hofman GA, van Oosterhout AJ. | Respir Res | 10.1186/1465-9921-5-21 | 2004 | ||
| Metabolism | Kinetic characterization of the soluble butane monooxygenase from Thauera butanivorans, formerly 'Pseudomonas butanovora'. | Cooley RB, Dubbels BL, Sayavedra-Soto LA, Bottomley PJ, Arp DJ. | Microbiology (Reading) | 10.1099/mic.0.028175-0 | 2009 | |
| Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. | Poyntz HC, Stylianou E, Griffiths KL, Marsay L, Checkley AM, McShane H. | Tuberculosis (Edinb) | 10.1016/j.tube.2013.12.006 | 2014 | ||
| Metabolism | Strong impact on the polycyclic aromatic hydrocarbon (PAH)-degrading community of a PAH-polluted soil but marginal effect on PAH degradation when priming with bioremediated soil dominated by mycobacteria. | Johnsen AR, Schmidt S, Hybholt TK, Henriksen S, Jacobsen CS, Andersen O. | Appl Environ Microbiol | 10.1128/aem.02236-06 | 2007 | |
| Current medical treatment for tuberculosis. | Chan ED, Iseman MD. | BMJ | 10.1136/bmj.325.7375.1282 | 2002 | ||
| Respiratory infections and asthma. | Pelaia G, Vatrella A, Gallelli L, Renda T, Cazzola M, Maselli R, Marsico SA. | Respir Med | 10.1016/j.rmed.2005.08.025 | 2006 | ||
| Genetics | Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa. | Ioerger TR, Koo S, No EG, Chen X, Larsen MH, Jacobs WR, Pillay M, Sturm AW, Sacchettini JC. | PLoS One | 10.1371/journal.pone.0007778 | 2009 | |
| Transforming Life: A Broad View of the Developmental Origins of Health and Disease Concept from an Ecological Justice Perspective. | Prescott SL, Logan AC. | Int J Environ Res Public Health | 10.3390/ijerph13111075 | 2016 | ||
| Current approaches and future directions in the treatment of leprosy. | Worobec SM. | Res Rep Trop Med | 10.2147/rrtm.s27395 | 2012 | ||
| Delayed hypersensitivity responses in mice and guinea pigs to Mycobacterium leprae, Mycobacterium vaccae, and Mycobacterium nonchromogenicum cytoplasmic proteins. | Watson SR, Morrison NE, Collins FM. | Infect Immun | 10.1128/iai.25.1.229-236.1979 | 1979 | ||
| Immunomodulatory properties of porins of some members of the family Enterobacteriaceae. | Alurkar V, Kamat R. | Infect Immun | 10.1128/iai.65.6.2382-2388.1997 | 1997 | ||
| Pathogenicity | Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters. | Moraski GC, Chang M, Villegas-Estrada A, Franzblau SG, Mollmann U, Miller MJ. | Eur J Med Chem | 10.1016/j.ejmech.2009.12.074 | 2010 | |
| Metabolism | Kinetics of methyl t-butyl ether cometabolism at low concentrations by pure cultures of butane-degrading bacteria. | Liu CY, Speitel GE, Georgiou G. | Appl Environ Microbiol | 10.1128/aem.67.5.2197-2201.2001 | 2001 | |
| Galleria mellonella-intracellular bacteria pathogen infection models: the ins and outs. | Asai M, Li Y, Newton SM, Robertson BD, Langford PR. | FEMS Microbiol Rev | 10.1093/femsre/fuad011 | 2023 | ||
| Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env. | Cayabyab MJ, Hovav AH, Hsu T, Krivulka GR, Lifton MA, Gorgone DA, Fennelly GJ, Haynes BF, Jacobs WR, Letvin NL. | J Virol | 10.1128/jvi.80.4.1645-1652.2006 | 2006 | ||
| DNA immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge. | Repique CJ, Li A, Collins FM, Morris SL. | Infect Immun | 10.1128/iai.70.7.3318-3323.2002 | 2002 | ||
| Induction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis. | Guirado E, Gil O, Caceres N, Singh M, Vilaplana C, Cardona PJ. | Clin Vaccine Immunol | 10.1128/cvi.00094-08 | 2008 | ||
| Metabolism | Peptide aMptD-mediated capture PCR for detection of Mycobacterium avium subsp. paratuberculosis in bulk milk samples. | Stratmann J, Dohmann K, Heinzmann J, Gerlach GF. | Appl Environ Microbiol | 10.1128/aem.00590-06 | 2006 | |
| Metabolism | Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation. | Miller AH, Haroon E, Felger JC. | Neuropsychopharmacology | 10.1038/npp.2016.167 | 2017 | |
| Respiratory Homeostasis and Exploitation of the Immune System for Lung Cancer Vaccines. | Yagui-Beltran A, Coussens LM, Jablons DM. | US Oncol | 10.17925/ohr.2009.05.1.40 | 2009 | ||
| Pathogenicity | Comparative transcriptome analysis of Methylibium petroleiphilum PM1 exposed to the fuel oxygenates methyl tert-butyl ether and ethanol. | Hristova KR, Schmidt R, Chakicherla AY, Legler TC, Wu J, Chain PS, Scow KM, Kane SR. | Appl Environ Microbiol | 10.1128/aem.01604-07 | 2007 | |
| Enzymology | Clinical application of PCR-restriction enzyme pattern analysis for rapid identification of aerobic actinomycete isolates. | Wilson RW, Steingrube VA, Brown BA, Wallace RJ. | J Clin Microbiol | 10.1128/jcm.36.1.148-152.1998 | 1998 | |
| Metabolism | Oxidation of methyl tert-butyl ether by alkane hydroxylase in dicyclopropylketone-induced and n-octane-grown Pseudomonas putida GPo1. | Smith CA, Hyman MR. | Appl Environ Microbiol | 10.1128/aem.70.8.4544-4550.2004 | 2004 | |
| Changes in pulmonary function and parasite burden in rats infected with Strongyloides venezuelensis concomitant with induction of allergic airway inflammation. | Negrao-Correa D, Silveira MR, Borges CM, Souza DG, Teixeira MM. | Infect Immun | 10.1128/iai.71.5.2607-2614.2003 | 2003 | ||
| Metabolism | Two new Mycobacterium strains and their role in toluene degradation in a contaminated stream. | Tay ST, Hemond HF, Polz MF, Polz MF, Cavanaugh CM, Dejesus I, Krumholz LR. | Appl Environ Microbiol | 10.1128/aem.64.5.1715-1720.1998 | 1998 | |
| What has Karonga taught us? Tuberculosis studied over three decades. | Crampin AC, Glynn JR, Fine PE. | Int J Tuberc Lung Dis | 2009 | |||
| The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection. | Hovav AH, Mullerad J, Davidovitch L, Fishman Y, Bigi F, Cataldi A, Bercovier H. | Infect Immun | 10.1128/iai.71.6.3146-3154.2003 | 2003 | ||
| Prior exposure to live Mycobacterium bovis BCG decreases Cryptococcus neoformans-induced lung eosinophilia in a gamma interferon-dependent manner. | Walzl G, Humphreys IR, Marshall BG, Edwards L, Openshaw PJ, Shaw RJ, Hussell T. | Infect Immun | 10.1128/iai.71.6.3384-3391.2003 | 2003 | ||
| Amyloidosis and the serum amyloid A protein response to muramyl dipeptide analogs and different mycobacterial species. | McAdam KP, Foss NT, Garcia C, DeLellis R, Chedid L, Rees RJ, Wolff SM. | Infect Immun | 10.1128/iai.39.3.1147-1154.1983 | 1983 | ||
| Use of multiepitope polyproteins in serodiagnosis of active tuberculosis. | Houghton RL, Lodes MJ, Dillon DC, Reynolds LD, Day CH, McNeill PD, Hendrickson RC, Skeiky YA, Sampaio DP, Badaro R, Lyashchenko KP, Reed SG. | Clin Diagn Lab Immunol | 10.1128/cdli.9.4.883-891.2002 | 2002 | ||
| Phylogeny | Application of the Sherlock Mycobacteria Identification System using high-performance liquid chromatography in a clinical laboratory. | Kellogg JA, Bankert DA, Withers GS, Sweimler W, Kiehn TE, Pfyffer GE. | J Clin Microbiol | 10.1128/jcm.39.3.964-970.2001 | 2001 | |
| A limited antigen-specific cellular response is sufficient for the early control of Mycobacterium tuberculosis in the lung but is insufficient for long-term survival. | Turner J, Dobos KM, Keen MA, Frank AA, Ehlers S, Orme IM, Belisle JT, Cooper AM. | Infect Immun | 10.1128/iai.72.7.3759-3768.2004 | 2004 | ||
| Serological expression cloning and immunological evaluation of MTB48, a novel Mycobacterium tuberculosis antigen. | Lodes MJ, Dillon DC, Mohamath R, Day CH, Benson DR, Reynolds LD, McNeill P, Sampaio DP, Skeiky YA, Badaro R, Persing DH, Reed SG, Houghton RL. | J Clin Microbiol | 10.1128/jcm.39.7.2485-2493.2001 | 2001 | ||
| In vivo repackaging of recombinant cosmid molecules for analyses of Salmonella typhimurium, Streptococcus mutans, and mycobacterial genomic libraries. | Jacobs WR, Barrett JF, Clark-Curtiss JE, Curtiss R. | Infect Immun | 10.1128/iai.52.1.101-109.1986 | 1986 | ||
| Metabolism | Propane monooxygenase and NAD+-dependent secondary alcohol dehydrogenase in propane metabolism by Gordonia sp. strain TY-5. | Kotani T, Yamamoto T, Yurimoto H, Sakai Y, Kato N. | J Bacteriol | 10.1128/jb.185.24.7120-7128.2003 | 2003 | |
| Immunotherapy for renal carcinoma: theoretical basis and current standard of care. | Vasey PA. | Br J Clin Pharmacol | 10.1046/j.1365-2125.2000.00300.x | 2000 | ||
| Enzymology | Clinical evaluation of the enhanced Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for rapid diagnosis of tuberculosis in prison inmates. | Bergmann JS, Yuoh G, Fish G, Woods GL. | J Clin Microbiol | 10.1128/jcm.37.5.1419-1425.1999 | 1999 | |
| Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. | Power CA, Wei G, Bretscher PA. | Infect Immun | 10.1128/iai.66.12.5743-5750.1998 | 1998 | ||
| Pathogenicity | The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. | Gehring AJ, Rojas RE, Canaday DH, Lakey DL, Harding CV, Boom WH. | Infect Immun | 10.1128/iai.71.8.4487-4497.2003 | 2003 | |
| Quantification of Gordona amarae strains in foaming activated sludge and anaerobic digester systems with oligonucleotide hybridization probes. | de los Reyes MF, de los Reyes FL, Hernandez M, Raskin L. | Appl Environ Microbiol | 10.1128/aem.64.7.2503-2512.1998 | 1998 | ||
| Molecular analysis of DNA and construction of genomic libraries of Mycobacterium leprae. | Clark-Curtiss JE, Jacobs WR, Docherty MA, Ritchie LR, Curtiss R. | J Bacteriol | 10.1128/jb.161.3.1093-1102.1985 | 1985 | ||
| Somatic influences on subjective well-being and affective disorders: the convergence of thermosensory and central serotonergic systems. | Raison CL, Hale MW, Williams LE, Wager TD, Lowry CA. | Front Psychol | 10.3389/fpsyg.2014.01580 | 2014 | ||
| Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. | Haroon E, Raison CL, Miller AH. | Neuropsychopharmacology | 10.1038/npp.2011.205 | 2012 | ||
| Genetics | Genome-Based Taxonomic Classification of the Phylum Actinobacteria. | Nouioui I, Carro L, Garcia-Lopez M, Meier-Kolthoff JP, Woyke T, Kyrpides NC, Pukall R, Klenk HP, Goodfellow M, Goker M. | Front Microbiol | 10.3389/fmicb.2018.02007 | 2018 | |
| Enzymology | Rapid and sensitive detection of Mycobacterium leprae using a nested-primer gene amplification assay. | Plikaytis BB, Gelber RH, Shinnick TM. | J Clin Microbiol | 10.1128/jcm.28.9.1913-1917.1990 | 1990 | |
| Stress | Comparing the effects of two different strains of mycobacteria, Mycobacterium vaccae NCTC 11659 and M. vaccae ATCC 15483, on stress-resilient behaviors and lipid-immune signaling in rats. | Loupy KM, Cler KE, Marquart BM, Yifru TW, D'Angelo HM, Arnold MR, Elsayed AI, Gebert MJ, Fierer N, Fonken LK, Frank MG, Zambrano CA, Maier SF, Lowry CA | Brain Behav Immun | 10.1016/j.bbi.2020.09.030 | 2020 | |
| Pathogenicity | Modulation of monocyte-tumour cell interactions by Mycobacterium vaccae. | Baran J, Baj-Krzyworzeka M, Weglarczyk K, Ruggiero I, Zembala M | Cancer Immunol Immunother | 10.1007/s00262-004-0552-6 | 2004 | |
| Genetics | Comparative evaluation of Mycobacterium vaccae as a surrogate cloning host for use in the study of mycobacterial genetics. | Medeiros MA, Dellagostin OA, Armoa GRG, Degrave WM, de Mendonca-Lima L, Lopes MQ, Costa JF, Mcfadden J, McIntosh D | Microbiology (Reading) | 10.1099/00221287-148-7-1999 | 2002 | |
| Phylogeny | Mycobacterium pyrenivorans sp. nov., a novel polycyclic-aromatic-hydrocarbon-degrading species. | Derz K, Klinner U, Schuphan I, Stackebrandt E, Kroppenstedt RM. | Int J Syst Evol Microbiol | 10.1099/ijs.0.03003-0 | 2004 | |
| Phylogeny | A new rapidly growing mycobacterial species, Mycobacterium murale sp. nov., isolated from the indoor walls of a children's day care centre. | Vuorio R, Andersson MA, Rainey FA, Kroppenstedt RM, Kampfer P, Busse HJ, Viljanen M, Salkinoja-Salonen M. | Int J Syst Bacteriol | 10.1099/00207713-49-1-25 | 1999 | |
| Phylogeny | Description of a novel species of fast growing mycobacterium: Mycobacterium kyogaense sp. nov., a scotochromogenic strain received as Mycobacterium vaccae. | Nouioui I, Brunet LR, Simpson D, Klenk HP, Goodfellow M | Int J Syst Evol Microbiol | 10.1099/ijsem.0.003039 | 2018 |
| #10934 | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 43292 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #36254 | ; Curators of the CIP; |
| #66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) . |
| #67770 | Japan Collection of Microorganism (JCM) ; Curators of the JCM; |
| #68382 | Automatically annotated from API zym . |
| #123767 | Collection of Institut Pasteur ; Curators of the CIP; CIP 105934 |
| #124043 | Isabel Schober, Julia Koblitz: Data extracted from sequence databases, automatically matched based on designation and taxonomy . |
| #125438 | Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 ) |
| #125439 | Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive132766.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data